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Abstract 
 
This thesis uses an innovative approach to explore the much-analyzed U.S. Healthcare system. 
To be sure, we are fully aware of the challenges involved in making robust system level policy 
recommendations and how local inefficiencies and hidden uncertainties undermine attempts 
proposing sweeping changes. Hence, we propose to investigate the Healthcare system using a 
supply chain perspective, which is inherently cross-functional and typically involves numerous 
different stakeholders. This holistic view will force us to think beyond artificial functional 
boundaries that promote local inefficiencies in the Healthcare system. Since the future is 
increasingly uncertain, we chose to use the scenario planning technique to guide the research 
process of developing effective system level policies. We will also leverage our insights to 
recommend new research directions to investigate the redefined system boundaries suggested by 
our scenarios.  
 
Since a Fortune 50 pharmaceutical company was used as a case study, the research focused 
primarily on a subset of the U.S. Healthcare system namely the U.S. pharmaceutical industry. 
The research also benefited from a series of workshops with supply chain executives from a 
variety of industries. These workshops helped us refine and validate the scenario planning 
methodology as a tool to think and plan for the long-term future in uncertain times. Furthermore, 
the analysis of U.S. Healthcare inefficiencies through a supply chain perspective resulted in 
some promising policy recommendations as well as exciting future research ideas. 
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1.  Introduction 
There is at least one consensus about the U.S. Healthcare system: it is in poor health. According 
to the international rankings and ratings by independent agencies, the quality of the U.S. 
Healthcare system is not commensurate with its very high price tag.  And, to make matters 
worse, the trend is on the up in terms of cost going forward.  Both, individuals and government 
are expected to pay significantly more for securing medical coverage and treatment. So what is 
the remedy?  
 
Countless policies and solutions have been suggested in the past to address the crippling 
inefficiencies rampant in this otherwise well functioning complex system. An often-quoted 
source of the problem is the heavy focus on local objectives which prevents the system from 
reaching global stability, and be efficient. Thus, in this thesis, we propose to explore the U.S. 
Healthcare system from a new holistic perspective –a supply chain perspective. Supply chains by 
definition interact with each and every aspect of product delivery mechanism from source to 
sink.  Supply chains are complex and intricate systems that involve numbers of different 
stakeholders. The premise is simple: looking at the U.S. Healthcare system through a supply 
chain lens will reveal new research directions to resolve prevailing inefficiencies. 
 
Unfortunately, it is already too late to solve inefficiencies plaguing the current Healthcare 
system. In short, inefficiencies are consequences of past strategies; hence, the future should be 
our main concern today. Furthermore, the ageing of the population, the steady increase in drug 
development costs and the globalization of health issues are among the numerous challenges that 
are bound to exacerbate the problems in the future. Not only do these trends paint a darker 
future, they also present new sources of uncertainty. How can we think and prepare the future in 
highly uncertain times where forecasting is increasingly difficult? We will argue in this research 
that accuracy of forecasts is less important and we can prepare for the future without leaning on 
accurate forecasts. To this end, we chose to revive and adapt a 30-year old methodology called 
Scenario Planning.  
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By combining the two approaches to think about the future of a very challenging industry, we 
aim to gain deep insights and propose directionally new solutions. In order to provide some 
background information about the different components of the research, we will discuss in some 
detail various concepts, ideas, and research projects that directly or indirectly supported this 
research. 
1.1 The Supply Chain 2020 Project 
The Supply Chain 2020 (SC2020)1 project is a multiyear research effort launched by the Center 
for Transportation and Logistics (CTL) to identify and analyze the factors that are critical to the 
success of future supply chains. This pioneering project will map out the process innovations that 
will underpin successful supply chains as far into the future as the year 2020. 
 
According to the project description, SC2020 is divided into three phases: 
Phase I: Understand excellent supply chains and the underlying strategies, practices, 
and principles that drive them. 
Phase II: Develop supply chain principles and leverage what is learned during the first 
phase, to project the future using scenario generation and planning methodologies. 
 
Phase III: In this phase the learning from previous two phases will be leveraged to outline 
a process for organization to develop supply chain strategy and prescribe actions that 
organizations should take to help ensure supply chain success in the future. 
 
A key finding of Phase I of SC2020 project was the importance of alignment between the 
business and supply chain strategy (Lapide, 2006). Indeed, the supply chain is also affected by 
the general business conditions that may or may not affect the business strategy directly as well.  
As a consequence, business macro factors tend to impact supply chain strategies twice directly or 
indirectly as shown in Figure 1.   
                                                
1 www.sc2020.net 
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Figure 1 What drives supply chains? 
1.2 The MEHD Project 
In Summer 2006, the Center for Transportation and Logistics (CTL) launched another research 
initiative called the MIT Efficient Healthcare Delivery Group (MEHD Group)2 to drive 
innovation in the Healthcare supply chain management sector. The research team decided to 
leverage its expertise in large-scale complex supply chains to study a domain that has 
traditionally been addressed in an operationally focused and fragmented ways.  The project is 
focused on gaining a deeper understanding of the driving forces and challenges in the Healthcare 
industry by looking at the six different supply chains that span the system – see Figure 2. 
Source: MIT-MEHD Website, http://ctl.mit.edu/index.pl?id=7405, accessed 04/05/07 
Figure 2 Simplified Model of Demand Flow in the Healthcare Supply Chain 
                                                
2 http://ctl.mit.edu/mehd 
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1.3 Research Scope 
Clearly, the dependence of supply chain strategy and design on external business macro factors 
poses significant challenge due to the presence of uncontrolled uncertainty. So, how can we plan 
for the future supply chain challenges in a dynamic and fast changing world? A typical approach 
to deal with this problem is to forecast the future macro factor trends, which has not proven to be 
reliable.  To avoid problems associated with forecasts, SC2020 considered alternate approaches 
to investigate the future of supply chains in the long run before settling on Scenario Planning.  
 
A key objective of this research was to support specific aspects of SC2020 and MEHD.  We 
decided to leverage scenario planning methodology for developing supply chain strategy under 
the SC2020 project to explore the future of the U.S. Healthcare system, which is at the core of 
MEHD. Our partnership with a Fortune 50 pharmaceutical company led us to further narrow our 
focus to consider only the future of the U.S. pharmaceutical industry (Figure 2) in this research.  
As part of the research process, we have conducted multiple scenario planning workshops and 
some of the results presented here are the direct outcomes of these efforts. 
1.4 Thesis Overview 
This thesis will first answer why the U.S. Healthcare and more specifically the pharmaceutical 
industry presents a challenge to long-term planning and why we chose scenario planning as the 
methodology to tackle this challenge in Chapter 2. In Chapter 3 we will analyze the current state 
of knowledge of both the U.S. Healthcare system and Scenario planning by presenting a review 
of the extant literature. In Chapter 4, we will leverage this knowledge to describe the state of the 
art in scenario planning.  Chapter 5 will discuss in detail our methodology to develop scenarios 
focusing primarily on the supply chain function in general as a case study. In Chapter 6, we will 
then apply our internally developed methodology to generate scenarios for the U.S. 
pharmaceutical industry from both a supply and a market perspective. Finally, we will propose 
potential next steps and present our key learning vis-à-vis the future of the U.S. pharmaceutical 
industry in Chapter 7, followed by key conclusions in Chapter 8. 
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2.  Problem Description 
2.1 The U.S. Healthcare System – A Future Full of Uncertainties 
The U.S. Healthcare system is not state-controlled unlike most other developed nations. It can be 
argued that it is primarily driven by a competitive private market, although the state plays a 
major role in the functioning of the overall Healthcare system i.e., controls approval of drugs, 
certification of medical professionals, as well as the biggest single payer of medical services. In 
other words, government does not appear as an active agent of change.   
 
According to economic theories, in a well functioning market, competitive forces through 
innovations etc. will drive the cost down and quality will rise over time. Yet, the U.S. Healthcare 
system is far from delivering what we could expect from any healthy competitive market as 
shown in Figure 3. The fact that the United States spend the most amount of money on 
Healthcare of all countries and still rank low on the service coverage and quality makes one 
question the justification of spending 16% of its 2004 GDP in Healthcare. 
Source: Wall Street Journal, “Health-Care Gold Mines: Middlemen Strike it Rich”, September 18, 2006 
Figure 3 U.S. Healthcare Underperformances 
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A majority of the problems in the U.S. Healthcare emerges due to the complexity of interactions 
between numerous stakeholders as shown in Figure 2. In the United States alone, the Healthcare 
supply chain involves more than 650,000 different organizations ranging from the manufacturer 
to the patient (Singh, 2007). In addition, the pharmaceutical industry is inherently uncertain due 
to the unique nature of pharmaceutical R&D process and the long FDA certification process.  In 
such conditions, exploring the future of the U.S. pharmaceutical Industry is a significant 
challenge? So, how should we go about exploring this future opportunities and problems to 
improve the effectiveness of the U.S. Healthcare system? 
2.2 Tackling Future Uncertainties: Different Approaches 
From the ancient times in Rome when Priests, the augurs, observed birds’ flights to the more 
recent craze about astrology, predicting future has been a central human preoccupation. In the 
business world, “hints”, trends or forecasts are regarded as potential sources of competitive 
advantages. To be sure, anticipating the unfolding future is considered a key to strategic 
advantage in our fast-changing world. 
 
Business decisions are usually differentiated in terms of scope and time horizon. They are often 
sorted into three main categories namely strategic, tactical and operational. A strategic decision 
requires considering the evolution of the world in the long term (multiple years) with a very wide 
scope of influence. A tactical decision on the other hand focuses mainly on the medium term 
horizon (few months to a couple of years) with a narrower scope of influence. And finally, an 
operational decision is centered on the future activities in the short term (few days to few 
months) and very specific scope. Different time horizons inevitably imply different levels of 
forecasting precision. Decades of experience have revealed that the accuracy and effectiveness of 
various forecasting technique is very subjective and depend on a multitude of factors but these 
dependencies can’t be rationalized. A key lesson for us is this: regardless of the forecasting 
technique employed, with longer time horizons, the level of accuracy plummets dramatically. 
 
 We believe most of the approaches used to plan for the future can be categorized into three main 
categories, namely point forecasting, risk management and scenario planning (Figure 4).  Indeed, 
this is a very well studied topic and it will be difficult to propose a comprehensive classification 
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of various techniques used for planning for the future, but it is our opinion that these three groups 
captures the differences between various techniques in an effective manner.  In the following 
paragraphs, we will then explain the main points of difference and convergence of these three 
approaches. 
 
Figure 4 Planning for One Future vs. Planning for Multiple Futures 
 
2.2.1 Point Forecasting  
When it comes to preparing or planning for the future, point forecast is a natural input. Based on 
the current situation and some historical data, point forecasting techniques attempt to provide a 
limited but precise description of the future end state (Figure 4). This approach is usually 
described as ‘looking at the future through your rearview mirror.’  Effectively speaking, these 
techniques suppress most uncertainties by making strong assumptions and “freezing” some 
variables. Interestingly, these assumptions can be easily challenged and changed which affect the 
accuracy of the forecast.  
 
While techniques such as the Moving Average or other Exponential Smoothing can offer some 
interesting insight in the short-term future, long-term predictions using statistical techniques are 
bound to fail.  The primary reason for this claim is the fact that it is impossible to include the 
effect of all events in the forecast that may take place in the future using historical data. That is 
- 16 - 
why focusing on a single point picture has enjoyed limited success in general and specially at the 
long-term strategic level.  
2.2.2 Risk Management (Range Forecast) 
Recognizing the presence of uncertainty and the limitation of point forecasting techniques, some 
organizations expanded the idea to include a small range of values that are possible instead of a 
single number.  This can be treated as an attempt to manage the risk arising due to uncertain 
future.  Although it relies on historical data, the uncertainties are not set to a specific level; 
instead, they are rationalized by limiting the values a variable/uncertainty can take. The possible 
fluctuation between a predetermined range allows decision makers to explore different projected 
end states (Figure 4).  In most cases, the range is arbitrarily defined by considering a ramp up or 
down amounting to +5%/-5% of the target value.  Nevertheless, risk management methodologies 
remain heavily dependent on the quality of the historical data since this tool still relies on the 
extrapolations of current trends. 
2.2.3 Scenario Planning  
Scenario Planning has been used by the military and large organizations to explore the future in 
the last few decades. The philosophy behind this method is applicable to different time horizons 
but scenario planning is particularly effective for long-term strategic decisions. 
 
The scenario planning methodology is motivated by the patent failure of forecasting tools to 
predict major disruptions such as oil crises or even the fall of the U.S.S.R. As a result, instead of 
focusing on one likely future, it proposes a few very “colorful” alternative pictures of the future 
to stimulate strategic thinking (Figure 4). Needless to say, the real future ends up being a mix of 
these multiple pictures but that is not the main objective of the scenario planning methodology 
any way, as we will discuss in the subsequent chapters. Acknowledging that the future might not 
unfold the way you thought is a key concept which challenges the current strategy and invites 
organizations to seek more robust solutions. In simple terms, scenario planning forces us to 
embrace uncertainties and make them a part of the decision making process rather than rejecting 
or limiting their influence. 
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2.3 Scenario Planning Approaches 
From simple numerical variation on “spreadsheet models” to complex sensitivity analysis, 
developing and interpreting scenarios may seem to be a well-developed business practice. To the 
contrary, there are numerous ways to create scenarios. We will explore various methods and 
techniques in this space but remain focused on those that strive to acknowledge and integrate 
uncertainty to bring awareness and stretch boundaries (this is our informal criterion for filtering 
out methodologies that define the scenario planning domain). 
 
Despite the “methodological chaos” that surrounds it (Bradfield et al., 2005), scenario planning 
follows a very strict and simple philosophy: open your mind, challenge your current vision of the 
future and try to “think the unthinkable” as Herman Kahn, the father of scenario planning, used 
to say (ibid.). Indeed, classical misinterpretations of scenario planning are common and usually 
lead to nothing else but fancy forecasts. As mentioned earlier, the key difference is that both 
forecasts and risk-management strongly rely on the perception of current trends and their 
extrapolations whereas scenario planning considers them as one of many inputs. 
 
In simple terms, Scenario planning advocates out-of-the-box thinking. Since a “best candidate” 
scenario is not identified and all scenarios are weighted equally. Accumulating alternative 
pictures forces decision makers to undertake a structured evaluation of complex uncertainties 
that directly or indirectly affect strategy.  In fact, this is the first step towards resiliency and 
robustness; this “what if” type of thinking challenges core assumptions and shed light on rigid 
weak points. 
 
 The recent shift in CIA’s approach to explore the future further corroborates our belief. In 1997 
and 2000, the CIA published the results of two major studies on the future: Global Trends for 
2010 and Global Trends for 2015 (CIA, 2000; CIA, 1997). These reports were based on 
extrapolations, which led to the identification of key potential trends; yet, both studies did not 
anticipate major disruptive events such as the 9/11 attacks, which undermined their validity and 
interest. That is why, in 2004, the CIA published its new long-term vision entitled ‘Mapping The 
Global Future’ based a scenario planning approach (CIA, 2004). 
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During the course of this research, we found out that scenario planning is a common practice in 
very uncertain times and rapidly transforming industries. Hence, this methodology seems 
appropriate for investigating the future of the U.S. pharmaceutical industry as it is undergoing 
rapid transformations on multiple fronts.  
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3.  Literature Review 
3.1 U.S. Healthcare Overview 
In our opinion the Healthcare system is characterized by great confusion especially due to one 
key issue: Who is the final decision-maker? Is it the patient, the doctor, or the pharmacist? Who 
is paying? Is it the patient, the Health Management Organization (HMO), the employer, or the 
U.S. government? In fact the word Healthcare itself is loosely defined as it encompasses both 
what we refer to as disease cure (post-symptoms intervention) and health care (pre-symptoms 
intervention) (Glouberman and Mintzberg, 2001a). In this thesis, we will focus on the cure of 
diseases and more precisely the related pharmaceutical business as mentioned in Chapter 1. 
 
In the Healthcare literature, numerous papers explain how and why the U.S. Healthcare system 
has failed to deliver high quality at a low cost as some other markets seem to be accomplishing 
e.g. computers, consumer goods etc. In some ways, the U.S. Healthcare system is a true enigma.  
Why does it behave so differently?  Why does it not follow the same evolution as other 
competitive markets? Porter and Teisberg argue that competition is at the root of the problem 
because competition does not occur at the right level; competition should be at the disease level 
not at the level of coverage (Porter and Teisberg, 2004). Instead of competing to reduce cost by 
all means, the market should have a simple common objective: “to increase value at the 
individual disease level.” It is unclear whether market or government failures have led to this 
sub-optimal state. Indeed the government intervenes through Medicare and Tricare but more as a 
player than a rule-maker. Therefore, in this thesis, we choose to focus on market failures as the 
main drivers for inefficiencies treating the government primarily as a follower.  
3.2 The Theory of Scenario Planning 
Countless papers present numerous ways to implement scenario planning; practitioners’ 
experiences have been adding up for the last thirty years.  Only recently have some papers 
proposed a structured listing of the different methods (Bradfield et al., 2005). Specifically, our 
approach to scenario planning capitalizes on the decades of work done in the Intuitive Logics 
domain popularized by the Royal Dutch Shell (Wack, 1985; Schwartz, 1996) and the recent 
compilations of practitioners’ knowledge (Fahey and Randal, 1998). 
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3.3 Scenario Planning: General Examples 
Examples of current scenario planning projects are easily available and fairly diverse ranging 
from major corporate actors (Shell, 2005; UPS, 2005) to entire industrial sectors (Penker and 
Wyrtzens, 2005) and governmental agencies (CIA, 2004) as mentioned earlier. 
 
Royal Dutch Shell has a long history of scenario planning and their Scenario Planning Group 
regularly publishes their research. Their latest exercise (Shell, 2005) provides scenarios of the 
world in 2025 in the form a book. These scenarios are built upon trade-offs situations between 
the three main world actors: governments, markets and communities. The book is divided into 
three parts: the first part presents the analytical framework whereas the second and third parts 
focus on the scenarios and the trends that will shape the future of the world. 
 
UPS also develops scenarios on a regular basis (UPS, 2005).  The purpose of their scenario 
exercise is to provide an effective framework to develop effective strategies for UPS in the 
future. Guided by scenario planning consultants, UPS has gone through the whole process of 
scenario generation to develop scenarios to prepare for the world till 2017.  Given the nature of 
their business, the scope of the exercise covered the entire world but for the purposes of 
developing actionable ideas, UPS has detailed the consequences of those pictures in key world 
regions: Americas, Europe and Asia. 
 
CIA has turned to scenario planning as well to develop its latest futuristic exercise “Mapping the 
Global Future” (CIA, 2004). This report is based on interviews with nongovernmental experts 
around the world. The four scenarios that were developed cover the entire world in 2020 but 
remains U.S. centric. These scenarios rely on a strong analytic framework supported by valuable 
data resources on future trends, which makes this report a great source of information. 
 
More importantly, these three examples of scenario planning are consistent in their approach: 
they all provide multiple pictures of the future by considering key uncertainties. They also 
provide valuable examples along with reliable sources of data on the future trends that might 
influence our future. 
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3.4 Scenario Planning: Pharmaceutical Industry Examples 
While global views like UPS, Shell and CIA scenarios fit the expected broadness of supply 
network scenarios, understanding the future U.S. pharmaceutical industry requires more focus 
and in-depth coverage.  This observation is important since the pharmaceutical industry is 
inherently very uncertain due to very specific and local factors such as the low acceptation rate 
of the FDA drug approval process. At the same time, many macro factors can completely 
transform the future of this industry rather quickly e.g. active government involvement in the 
Healthcare. The diversity of drivers and high level of uncertainty explains why scenario planning 
was chosen as a methodology in two prominent projects in this space namely, Pharma Futures 
(Pharma Futures, 2004) and a Deloitte Research report (Deloitte, 2002). 
 
The Pharma Futures project (Pharma Futures, 2004) is a British scenario planning project under 
the aegis of three pension funds: Algemeen Burgerlijk Pensionenfonds (ABP Netherlands), the 
Ohio Public Employees Retirement System (OPERS, US) and the Universities Superannuation 
Scheme (USS, UK). These three pension funds are major stakeholders in the pharmaceutical 
industry and “were aware of the limited utility of the traditional tools available to manage risk.” 
Therefore, Pharma Futures gathered fifteen private sector stakeholders (pension funds, sell and 
buy-side analysts, pharmaceutical executives from ethical/branded and generic firms) to develop 
pictures of the sector in the next ten to fifteen years. As a result of this exercise three scenarios 
were developed: the Producers Scenario, the Patient Scenario and the Political & Public Health 
Scenario. Each scenario is a chronological story told from one key stakeholder’s perspective 
namely the producers, the patient and the public sector. 
 
The Deloitte Research report titled “Strategic Flexibility in Life Sciences” presents four 
scenarios to propose a framework on how to build flexibility in the Life Sciences business 
(Deloitte, 2002). The four scenarios are purposefully “basic” as they just exist to illustrate the 
overall framework. They are built on 2 by 2 matrix defined by two axes: “industry maintains 
pricing power?” - Yes or No - and “bio-science advances translate to clinically useful products?” 
- Yes or No. Despite the simplistic process of scenario generation, this report provides many 
insights by investigating the major uncertainties on the demand-side, the supply-side and the 
socio-political side. Some pharmaceutical companies use scenario planning on a regular basis. 
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4.  Scenario Generation: A State of the Art 
A quick scan of the literature will suggest that there is an abundance of publications that would 
provide enough guidelines for any beginner to start his/her own scenario very easily and quickly. 
Yet, to gain an in depth understanding of the scenario planning field demands an extensive 
information gathering effort through a detailed literature review. Our experience suggests that 
practitioners’ perspective outnumbers the few papers that propose a structured view of scenario 
planning.  
 
Indeed, the methodology focused literature is colored by the respective experiences of the writer 
and thus unique in character. Even though each scenario planning exercise is unlike any other 
because it has to be tailored to fit a specific objective, there are some common patterns that 
should be leveraged to make use of the existing knowledge instead of reinventing the wheel each 
time.  To this end, we argue that a normalized approach to scenario planning will produce great 
results and yet easily replicable.   
 
Interestingly, there is no clear consensus in literature about how to define the term scenario. As 
the next sections will prove, there is no general agreement on what should be the output of a 
scenario generation exercise. This flexibility of interpretation invited us to rigorously define the 
terminology to facilitate understanding. Before proceeding further, we would like to make a 
distinction between an ‘end state’ and a ‘scenario.’ We define an end state as a static picture of a 
future situation. It is like a painting and provides a snapshot of the events taking place at a given 
moment in time. On the other hand, a scenario is a dynamic picture of a plot, a sequence of 
events that tells a developing story.  
 
It is our core belief that scenario generation requires a clear understanding of the drivers of 
change that will shape the end states. Thus, in our approach, a scenario can either be a path of 
events leading up to a particular world or an end state coupled with the understanding of driving 
forces guiding its evolution. 
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4.1 Three Main Schools 
Some research teams have attempted to propose a classification of scenario generation 
methodologies to defog the prevailing confusion. The latest intent (Bradfield et al., 2005) is 
worth noticing for its clarity and comprehensiveness. Based on a thorough literature review and 
the analysis of the origins and growth of scenario development models, they identify three main 
schools of scenario planning: the Intuitive Logics, The Probabilistic Modified Trends and La 
Prospective.  
 
 The Intuitive Logics approach is based on the work done by H. Khan. Pierre Wack promoted 
this approach during the early years of Shell Scenario development process. A detailed 
discussion of this school is provided in the next section. 
 
 The Probabilistic Modified Trends (PMT) approach incorporates two distinct methodologies: 
Trend-Impact Analysis (TIA) and Cross-Impact Analysis (CIA). TIA and CIA can be 
classified as probabilistic forecasting tools; nevertheless, “they generate a range of alternative 
futures rather than a single point naïve extrapolation of historical data, and when combined 
with judgments and narratives about the events in these futures, they constitute scenarios” 
(ibid.) 
 
 La Prospective, also known as the French School’s approach, relies on the quantitative and 
qualitative analysis of trends and the risks of discontinuities (breakdowns or breakthroughs) to 
develop scenarios (Godet, 1997). 
4.2 The Intuitive Logics Approach 
The initial objective of our team was to adopt a process minded approach to scenario planning 
that would allow us to identify the activities that can be easily standardized and focus resources 
where value is really created.  Furthermore, the process had to be adaptable to all types of 
industries and supply chains.  
 
As mentioned earlier, our informal criterion for filtering out methodologies was twofold: the 
increased awareness and the stretching of mental boundaries.  Therefore, we feel strongly about 
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the commonly accepted practice requiring that all scenarios shall be coherent, comprehensive, 
internally consistent and logical. A key differentiation of this approach from risk management 
domain is the assignment of equal weight to all scenarios. We assert that quantifying the 
likelihood of various scenarios amounts to picking a winner between scenarios, which indirectly 
undermines our objective of broadening decision maker’s perspective and challenging current 
business assumptions. Moreover, to emancipate ourselves a little bit more from the popular 
forecasting practices, we chose a primarily qualitative approach to force a data independent 
thinking.   
 
To select a suitable approach based on our pre-requisites, we analyzed different potential 
methodologies. Table 1 summarizes the factors we considered before selecting our approach. 
 
 Intuitive Logics La Prospective PMT 
Scenario 
Architecture 
Coherence, comprehensiveness, internal consistency, logical 
underpinning 
Scenario 
Evaluation 
All scenarios are 
considered equally 
plausible. 
Scenarios are plausible and verifiable in 
retrospect. Probabilities are attached to 
future events. 
Methodological 
Orientation 
Process-oriented. 
Insights gathered along 
the process are more 
important than the 
output. 
Outcome oriented. The reliability of the 
end results is critical. 
Scenario Output Qualitative Quantitative and Qualitative Quantitative 
Identification of 
Key Driving 
Forces 
Intuition, sets of usual 
macro factors and 
research 
Interviews and 
comprehensive 
structural analysis 
using computer tools 
Trends identified in 
historical time 
series data 
Table 1: Factors that shaped the methodological lock-in 
 
Thus, the Intuitive Logics Methods with its flexibility and its clear emphasis on process and 
insights best suited our needs. As expected, several variations of this method are described in the 
literature, however, it appears that most of them can be categorized into two main groups, 
namely the inductive or bottom-up approach and the deductive or top-down approach (Figure 5.) 
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Figure 5 Different Approaches to the Intuitive Logics Method 
 
4.2.1 The inductive or bottom-up approach 
This method consists of “project[ing] sets of plausible futures based on analysis of present forces 
and their likely evolution” (Fahey and Randall, 1998, Chapter 1). Five key steps of inductive 
approach are (see Figure 6) 
 
STEP 1. Define what is precisely the question you want to answer e.g. what will the 
competition look like in twenty years from now?  
 
STEP 2. Identify what factors impact or will impact your activity; those can either be 
internal or external to your organization. Identifying those factors is critical to the 
rest of the process.  
 
STEP 3. Analyze and sort factors in Step 2 in terms of strength of impact and degree of 
uncertainty. 
 
STEP 4. Aggregate critical factors (high uncertainty and high impact) to create axis that 
scenarios will explore.  
 
STEP 5. Narrow down the possibilities to two main axis i.e. 4 scenarios overall. 
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Figure 6: Inductive Approach 
 
4.2.2 The deductive or top-down approach 
This method consists of “select[ing] several significant futures and try to discover the paths that 
lead to them” (ibid.). The deductive approach can be divided into five major steps (see Figure 7) 
 
STEP 1. Develop a precise definition of the question you want to answer.  
 
STEP 2. Identify key assumptions, premises and beliefs that will dramatically shape your 
future e.g. major supply disruption.  Based on that, envision events that would 
embody these assumptions e.g. China drifts away from WTO, the European Union 
collapses or even a major worldwide pandemic. 
 
STEP 3. Build provocative short stories around the previously identified “events”. This 
will constitute a set of end states -snapshots of the world in the future. This step is 
surely constrained by both the creativity and the bias of the group in charge. 
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STEP 4. Present the end states to insiders i.e. organization’s members external to the team 
that developed the end sates. Invite them to focus on what would happen if the 
world unfolded as in each end state.  
 
STEP 5. Guide the group discussion to develop plausible paths that could describe the 
evolution of the world from today to each end state. This step increases insiders’ 
exposure to all the uncertainties that could threaten the company’s vision of the 
future. It forces them to identify the drivers of change in their current and future 
environment and increase the overall company awareness. 
 
 
Figure 7: Deductive Approach 
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4.3 Infinite Possible Variations 
One should notice that the distinction between inductive and deductive approaches is mostly 
academic. Indeed, they both have the same threefold objective: to identify “driving forces”, to 
take into account “predetermined trends” and to spot “critical uncertainties” as proposed by Peter 
Schwartz (Schwartz, 1996). In the end whatever method we use to undertake scenario 
generation, it is all about understanding and analyzing: 
 
 What we know we care about – the driving forces; 
 What we know, we know – the predetermined trends; 
 What we know, we don’t know – the critical uncertainties. 
 
In other words, the inductive and deductive approaches are just two paths to get to the same 
place and practice reveals that those paths are highly intertwined. A close examination of two 
large scenario generation exercises (Shell, 2005; UPS, 2005) demonstrates that practitioners 
consciously or unconsciously mix these two approaches to enhance the output.  
 
For example, the 2005 Shell Scenarios are built on the assumption that the world is facing a dual 
crisis of trust and security and this crisis will shape the future of the whole world. Shell identifies 
three main forces whose interplay will generate answers to the crisis: “Market incentives”, 
“Coercion / Regulation” and “The force of community”. These forces are likely to express 
through trade-offs three potential end states (Figure 8).   
 
It may appear that Shell chose a deductive approach; yet, a closer examination highlights a more 
complex construction. Effectively, the fundamental rationale that led to the creation of end states 
is inductive: Shell spots a major driving force (the dual crisis) and then considers uncertainties 
around it. Shell concluded that the selected forces will interact in different ways to solve this 
crisis.  If we eliminate the three utopias (one force outweighs the two other) we are left with 
three situations of “two wins-one loss” trade-off each. 
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Source: Shell Presentation at Davos 04 
Figure 8: Shell Scenarios 
 
Likewise, the UPS Horizon 2017 seems to follow a pure inductive approach. The key driving 
forces are determined first, followed by the uncertainties and then, the aggregation of the latter 
into two major axes namely the “Nature of the Field” and the “Nature of the Game” (Figure 9).  
 
Yet, a deductive methodology comes into play when the short stories are developed.  Even 
though the direction is clearly given, the content of the stories crystallizes UPS biased 
assumptions about the future. Those biased stories are then studied by following the classical 
deductive framework (STEP 4 and 5 – Section 4.2.2.). 
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Source: UPS Presentation, MIT SC2020 Symposium, 11/29/05, Cambridge, MA 
Figure 9: UPS Scenarios 
 
Hence, one can argue that Shell exercise is mainly deductive and UPS’s mainly inductive. But, 
these examples prove that it is neither necessary nor easy to develop a pure inductive or 
deductive approach. Furthermore, given the architecture of the human brain, cultural biases and 
people’s relative sensitivity to future or present is bound to make these two approaches blend in 
any scenario generation.  
 
Philosophers such as Charles Sanders Peirce decompose the human logical system into three 
stages: abduction, deduction and induction (Yu, 1994).  Peirce introduces the logic of abduction 
as a prerequisite to any qualitative or conceptual understanding of phenomena. Abduction 
explains how we decide to select hypothesis that are worth studying. Abduction consists of 
spotting patterns in a phenomenon and suggesting a hypothesis. The objective is to decide which 
hypothesis or proposition to test. For instance, why did Shell decide to take the dual crisis of 
trust and security as premise for their scenarios? In all likelihood, the observation of recent 
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events such as the 9/11 attacks and the Enron scandal led them to hypothesize that a dual crisis 
will emerge and shape our future. Then, in the Peircean system, the plausible hypothesis is 
refined through logical deduction. Deduction draws logical true consequences from premises, 
given the premises are true. Finally, induction provides the empirical justification by inferring a 
general law based on numerous cases and empirical evidence.  
 
Following this approach, broadly speaking, at the stage of abduction, we explore data, look for 
patterns and suggest a plausible hypothesis; deduction builds logical and testable hypothesis on 
plausible premises and induction is the approximation towards the truth in order to fix our beliefs 
for further inquiry (Yu, 1994). In short, abduction, deduction and induction are all part of the 
same logical phenomenon. 
 
In summary, there are nearly as many methods as scenarios generation exercises presented in the 
literature. Although a classification of the main characteristics remains valuable, any attempt to 
report those methodologies in an aggregated fashion (i.e. mainly inductive vs. mainly deductive) 
would be futile. 
 
4.4 SC2020 Approach: Market and Supply Network Analysis  
It is our core belief that scenarios targeting supply chain function or having a supply chain 
perspective should paint a rich picture of both the demand and the supply side. As mentioned 
earlier, the supply chain strategy alignment is one of the key learnings of the SC2020 project 
(Lapide, 2006).  As a result, a good understanding of the market forces affecting demand and 
business strategy is necessary before developing an effective supply chain response. To this end, 
we propose a two-step framework to generate global scenarios that will allow decision makers to 
explore rich demand and supply issues.  
 
In step one, we develop market and supply network scenarios followed by step two which 
involves the merger of these two scenarios into multiple global scenarios – see Figure 10. Note 
that objectives of market and supply network analysis are quite different. The market scenarios 
present challenging pictures of the future to stimulate discussions around potential business 
strategies and different competitive advantages at the company level. The supply network 
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scenarios present a broad array of possible supply investment opportunities and threats. Being 
very different in scope and objective, we decided to use two different methodologies to generate 
these scenarios. 
 
Figure 10 Overall Framework 
 
 
In Chapter 5, we will describe the supply network analysis process, which leverages our existing 
supply chain scenarios.  In SC2020, the supply network analysis chronologically came first and 
constituted a learning experience that allowed us to develop a better-suited methodology for the 
market analysis.  
 
Next, in Chapter 6, we will explain the process followed to develop market scenarios for the U.S. 
Healthcare. The understanding of the broad challenges of the Healthcare system allowed us to 
identify key uncertainties that are likely to shape its future; these uncertainties were the main 
input to the scenario generation exercise. 
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5.  Supply Network Analysis 
In this chapter, we will describe the process used to develop SC2020 generic supply network 
scenarios in Phase II of SC2020. These non-industry specific supply chain scenarios were 
leveraged to develop three supply network scenarios for the U.S. pharmaceutical industry.  
5.1 A Modularized Scenario Generation Process 
5.1.1 Why a new approach? 
In order to explore the future supply network environment, we need to identify and understand 
the macro factors that go well beyond the current boundaries of the business domain e.g. security 
crises in the world, pandemics, etc. Scenarios for supply network analysis should be non-industry 
specific to be as challenging and exhaustive as possible. Thus, the scope of these scenarios was 
very broad, yet the scenarios had to be granular enough to allow effective strategizing. Given 
these requirements, we decided to utilize both the deductive and the inductive methodologies to 
exploit their respective strengths.  A comparison of the strengths and weaknesses of these 
methodologies is provided in Table 2. 
 
 Strengths Potential Weaknesses 
Deductive 
Approach 
- Broad perspective; 
- All inclusive; 
- Easy way to engage people. 
- High degree of abstraction needed 
to draft the end states; 
- Overlooks specific issues that 
might become more critical in the 
future; 
- Possible influence and limitations 
due to the constructing team bias. 
Inductive 
Approach 
- Focus on the critical forces;                                
- Customizable to fit company/activity; 
- Possibility of detailed scenarios with 
high granularity. 
- High degree of abstraction needed 
to create stories from a set of 
driving forces; 
- High risk of missing macro 
factors that will shape the overall 
market. 
 
Table 2 Deductive and Inductive Strengths and Weaknesses 
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Our objective was not only to develop scenarios for the project’s purposes but also to identify a 
framework that would facilitate the supply network scenario generation. We observed that 
scenario generation is a very time and resource consuming activity because people tend not to 
leverage the resources already available in the public domain. Thus, we developed a process-
minded approach called the Rapid Scenarios approach. This methodology utilizes both the 
strengths of the deductive and inductive approaches. 
5.1.2 The Rapid Scenarios (RS) Approach 
The RS approach consists of steps that refine already existing scenarios to incorporate the critical 
factors relevant to the question under investigation. 
 
Indeed, the selection of preexisting scenarios clearly reduces the time and resource constraints. 
These scenarios are used as the end states described in the deductive approach. Then, it shifts the 
focus to steps that really create values. Yet, to increase the relevance of these scenarios, macro 
forces are identified as in the inductive approach. The selected scenarios are then processed to 
emphasize the importance of the key driving factors.    
 
 
Figure 11 A New Approach to the Intuitive Logics Method 
 
The RS approach benefits both from the momentum generated by the deductive methodology 
and the high degree of granularity extended by the inductive methodology. The deductive 
methodology relies on a strong dynamics of causality but overlooks the identification of the 
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factors that should be monitored. On the contrary, the inductive methodology really focuses on 
“what we care about” but the analysis of those factors is burdensome, which decreases people’s 
interest in the scenario generation exercise. Thus, the RS approach benefits from the strengths of 
both logic methods while avoiding their main disadvantages. 
5.1.3  “Building Blocks” 
The RS approach finds its roots in process analysis i.e. looking at scenario planning through an 
engineering lens. The key objective was to design a flexible framework that could be easily 
applied everywhere by everyone. Hence, the process must be straightforward and clearly state 
the inputs and outputs of each step. We adopted a modular structure using building blocks based 
on five simple steps described below. 
 Definition of the Objective 
First and foremost, it is important to precisely define the question we want to answer (Step 1 in 
Figure 12). Then, search for scenarios in the public domain using some of the resources 
suggested in Chapter 3. After analyzing potential candidates in terms of geographic and 
macroeconomic scope, timeframe, general relevance for your industry, etc. choose the “off-the-
shelf” scenarios that best fit the stated objective (Step 2 in Figure 12). 
 
 Filter Creation 
Create the filter that will allow identification of relevant information vis-à-vis the question under 
consideration as described above (Step 3 in Figure 12). Simply put, this filter is a list of major 
points that should be covered in the scenarios. Interviews and/or some literature review can help 
develop this list. This step is equivalent to the Step 2 of the inductive approach: identify the 
driving forces (Figure 6). 
 End States Creation 
Process the scenarios using the filter developed above (Step 4 in Figure 12). After highlighting 
the major factors identified previously, rewrite the scenarios as a description of the future to 
obtain a set of end states. 
 
- 36 - 
Ideally, these end states should be presented to insiders i.e. organization’s members external to 
the team that developed the end sates. Invite them to focus on what would happen if the world 
unfolded as described in each end state. Guide the group discussion to develop plausible paths 
that could describe the evolution of the world from today to each end state. The end states along 
with possible set of events describing a possible path constitute a scenario (Step 5 in Figure 12).  
  
Figure 12 From the Definition of the Objective to the Scenario Finalization 
 
We previously acknowledged (see beginning of Chapter 4) that the identification of a path of 
events was sufficient but not necessary. Indeed, reflecting on possible paths serves a particular 
purpose as it helps the team identify a set of key variables that should be monitored as the future 
unfolds. We refer to these variables as “sensors in the ground.” These “sensors in the ground” 
can also be discussed with end states to assess the effects of such a world on a supply network. 
Our experience corroborated the fact that such “enriched” end states can also be rehearsed as 
effective scenarios 
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 Scenario Finalization 
End states or scenarios are usually well received but they never answer the critical question that 
is in every manager’s mind: So what? To answer this question and ensure a good understanding 
of the challenges and opportunities that such a new environment can create, a list of challenging 
questions is presented to the participants in order to stimulate their thinking and encourage 
engagement. These questions also serve the purpose of prioritizing and clarifying potential ideas 
for strategy development.   
 
Once participants have a better understanding of the direct effects of future uncertainties and 
macro forces on their strategy, it is an opportune time to ask what events can possibly lead to 
such a scenario? To be followed by a question on the drivers that should be closely monitored? 
This discussion is an alternative to the path creation process presented in the previous section. 
 
In essence, this step is an application of the Socratic method. Thus, it either requires a very well 
designed questionnaire or a facilitator who has mastered inquiry methods to reveal mental 
models such as the one described in Peter Senge’s book “The Fifth Discipline” (Senge, 1990).  
5.2 SC2020 Three Supply Network Scenarios 
This section describes how we applied our Rapid Scenarios approach to explore the future of the 
U.S. pharmaceutical industry supply network. 
5.2.1 Definition of the objective 
What will the U.S. pharmaceutical Supply Chains look like in 2020? We set out to explore this 
question in a non-industry specific manner using the ideas developed under SC2020. Indeed, as 
discussed earlier, supply network concerns are global and mainly non-industry specific. The 
scenarios developed through the RS approach offered a broad array of situations as they provided 
a glimpse of the future of the supply network in almost any industry. 
 
We decided to use the scenarios developed by Shell (Shell, 2005) as our ‘off-the-shelf’ scenarios 
as these scenarios are developed based on extensive research and built on detailed information 
from a variety of sources. Moreover, a company like Shell is present all over the world and the 
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performance of their business is directly affected by the situation in any geographical area or any 
section of the economy. Hence, their scenarios contain an insightful picture of how macro-forces 
such as demography or terrorism may shape the future of the world. These scenarios constitute 
one of the best publicly available resource as far as macro pictures are concerned. 
5.2.2 Filter Creation 
Following the RS approach, we needed a filter to recast the Shell scenarios to make them more 
relevant for our purpose.  To this end, we used the information on drivers of supply chain design 
and key challenges based on an extensive literature review by Singh (Singh, 2004). This review 
represented the consensus within the supply chain community about what the future driving 
forces or macro-factors will look like and how they will shape supply chain design. This analysis 
underlined some common patterns that needed to be embedded in our scenarios to be effective. 
As a result, the ideas expressed in literature were used as a “supply chain filter” to process Shell 
scenarios by highlighting the factors that will be critical to supply chain design.  
 
But, incorporating external supply chain concerns into existing scenarios without undermining 
the integrity of the base stories is not easy. The RS approach proposes the customization of 
already existing scenarios by incorporating the respective concerns of a company or activity and 
certainly a challenge (Figure 13). This step requires creativity and ingenuity on part of the 
scenario development team and more or an art than science. 
 
Figure 13 The Processing of Shell Scenarios 
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The SEPT (Social Economic Political Technology) framework (Fahey and Randall, 2004, p. 87) 
inspired us to classify the most prevalent supply chain concerns (Singh, 2004) under eleven 
macro-factor categories as presented below: 
- Trade and Protectionism 
- Global Security and Trust 
- Market Forces 
- Competition and Alliances 
- Financial Market Forces 
- Social and Lifestyle Factors 
- Labor Forces 
- Environmental Constraints 
- Technological Forces 
- Natural Resources 
- International Political Environment 
 
Finally, the supply chain filter took the form of a 3 X 11 matrix where every macro-factor is re-
interpreted to match the three Shell scenarios storyline i.e. “Open Doors”, “Low Trust 
Globalization” and “Flags” (Shell, 2005). If the supply chain concern reflects the scenario 
storyline, it is captured in the matrix. Due to the limited information in the literature, we were not 
able to fill every cell for every scenario. Some rewriting was generally required. In other words, 
the information filled in the matrix relied on our interpretation of extant supply chain concerns 
(Singh, 2004) according to the general plot of each scenario (Table 3). 
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Table 3 Supply Chain Filter From Literature Review 
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5.2.3 End State Creation 
We used the eleven macro-factors as “reading grid” for the three Shell scenarios. We recast the 
final result of our analysis into another 3 X 11 matrix. This information was a collection of 
quotes from each Shell scenario that gave a direct description of a given macro-factor (Table 4). 
 
T
ra
de
 &
 
P
ro
te
ct
io
ni
sm
G
lo
ba
l 
S
ec
ur
it
y 
&
 
T
ru
st
M
ar
ke
t 
F
or
ce
s
C
om
pe
ti
ti
on
 &
 
A
ll
ia
nc
es
F
in
an
ci
al
 M
ar
ke
t 
F
or
ce
s
S
oc
ia
l 
&
 L
if
es
ty
le
 
F
ac
to
rs
L
ab
or
 F
or
ce
s
E
nv
ir
on
m
en
ta
l 
C
on
st
ra
in
ts
T
ec
hn
ol
og
ic
al
 F
or
ce
s
N
at
ur
al
 R
es
ou
rc
es
In
te
rn
at
io
na
l 
P
ol
it
ic
al
 
E
nv
ir
on
m
en
t
Extracted information on each macro-factor in each 
of the three scenarios (Shell, 2005)
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Table 4 Supply Chain Filter From Re-Reading of Shell Scenarios 
 
Then, we merged the two matrices and used the combined information as a canvas for the 
rewriting of three end states (Table 5). After we were done with the process the new end states or 
snapshots of the world in 2020 bore little or no direct resemblance with the Shell scenarios 
except a close storyline (Figure 12). The end states were then re-titled to ensure the necessary 
scenario ownership. 
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Table 5 Final Supply Chain Filter 
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A quick summary of the resulting end states namely, “Synchronicity”, “Alien Nations” and 
“Spin City” is presented in Figure 13. The complete story is available for a curious reader in 
Appendix I. We would like to express our gratitude to Ken Cottrill, MIT-CTL Global 
Communications Consultant, for developing compelling stories. 
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Source: Senior Executive Workshop, Cambridge, MA, January 4, 2007 
Figure 14 Three Supply Network End States – Story Line 
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Source: Senior Executive Workshop, Cambridge, MA, January 4, 2007 
Figure 15 Three Supply Network End States – Summary 
 
 
 
 
Synchronicity 
Democratic ideals have taken hold across the globe, and intrinsic to these ideals is the notion that all 
parties – whether they be individuals, companies or governments – must trust each other. In this 
world, trust does not impede business or societal relationships - it promotes them. As a result, 
untrammeled global commerce flourishes in Synchronicity world, to such an extent, that a major 
challenge for companies is keeping up with constantly shifting market demands and technological 
breakthroughs. Qualities such as trustworthiness and integrity are essential to business success. Life is 
rich but frenetic, and people like to sample as much of it as they can. They change jobs frequently, 
another challenge for companies that increasingly rely on “knowledge workers” to create the 
customized products and services that are in demand. Environmental protection has become universal 
aspiration.   
 
Alien Nation  
Citizens of the Alien Nations world think and 
act locally. Foreign peoples and governments 
are mistrusted or even disdained; globalization 
does not even warrant lip service from a 
political establishment hemmed in by 
nationalism. Energy is a hot-button issue 
because countries are in competition for 
dwindling natural resources. Conservation and 
energy efficiency policies are being pursued 
with vigor. The lack of standardization across 
global trading and commercial systems makes 
international expansion risky and expensive. 
Trade barriers are strewn across the world. Not 
surprisingly, companies focus their endeavors 
on national markets and customers. A major 
threat to world stability is unsynchronized 
business cycles and investment strategies, a 
symptom of the lack of global unity. 
Nationalistic attitudes obstruct emigration, even 
though there is a high demand for younger 
migrant workers in many countries. In the 
Alien Nations world charity begins - and ends – 
at home. 
 
Spin City 
Terrorism and tensions between countries have 
reached such a pitch that trust and national 
security issues dominate political and corporate 
agendas. Globalization remains a powerful 
force, but hamstrung by a complex web of 
conflicting regulations. Governments are 
intervening more and more to strengthen 
security and paying less attention to their 
markets in an increasingly complex trading 
environment. As a result, markets are not as 
efficient as they could be, and managing 
change is a major challenge since the ground 
rules for trade are in a constant state of flux. 
Trust is a distinct competitive advantage.  To 
compete globally, companies have to build 
solid reputations for being trustworthy. Highly 
innovative enterprises that can exploit the new, 
but fleeting, business opportunities around the 
globe that are a feature of this fast-changing 
world are also in a strong competitive position. 
The conflict at the heart of this world is: should 
regulation or market forces champion trust and 
physical security?  
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5.2.4 Scenario Finalization 
To validate the effectiveness of the new scenarios, we tested them at three different events: two 
SC2020 Advisory Council workshops (IAC, Louisville, KY, 06/22/06 and EAC, Zaragoza, 
Spain, 04/07/06), and one Senior Executive Workshop held at Cambridge, MA on 01/04/07. In 
the latter workshop, supply chain executives from various industries used the Harvard case study 
on Sport Obermeyer Ltd. (Hammond and Raman, 1994) as the background to analyze the 
implications of each scenario on the company’s supply network.  
 
We provided the framework shown in Figure 16 to guide the brainstorming sessions. Although 
offering little practical insights, the workshop demonstrated the power of the scenarios in 
initiating rich dialogue between the participants.  As expected, the answers varied by groups and 
a further analysis would be necessary to gain better understanding in an actual situation.  
 
Source: Senior Executive Workshop, Cambridge, MA, January 4, 2007  
Figure 16 Scenario Finalization Framework 
Scenario Finalization Framework 
1. What are the key characteristics and features of the supply network to fulfill the type of 
market and demand discussed above? 
a. What will be the focus of the supply network design: 
i. Customer responsiveness 
ii. Asset utilization 
iii. Operational efficiency 
b. Supply chain organization: 
i. Vertically integrated 
ii. Horizontally integrated 
iii. Virtually integrated 
c. What should be the key strengths of this supply network? 
d. What are the key weaknesses of this supply network and what should we 
watch out for to avoid major problems? 
e. Other issues we should think about: 
i. Complexity 
ii. Resiliency 
 
2. What will be your supply chain investment strategy keeping in mind the key capabilities 
needed to support the supply network design? (Which corporate function will be more 
important requiring investment to enhance capabilities? 
a. People 
b. IT tools and techniques 
c. Domestic versus international sourcing 
d. Outsourcing of components or insourcing 
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Before discussing ways to analyze different responses from various groups to arrive at actionable 
outcomes, we would like to highlight a critical aspect of scenario planning and our proposed 
approach.  Let us draw a pictorial analogy by showing each set of opinions from different groups 
in a different color as in Figure 17.  Notice how each color (opinion) is different from each other 
in the top line and of limited value by itself.  A focus on consensus building results in 
undermining the rich variety by creating an overriding new shade (opinion). Whereas using 
collaborative profiling, as done in scenario thinking, the coexistence of colors (opinions), leads 
to an enrichment of the different opinions instead of their replacement with a common view i.e. 
the official future. We will not discuss this process any further as it is well beyond the scope of 
this thesis. 
 
 
Source: Senior Executive Workshop, Cambridge, MA, 01/04/07 
Figure 17 Collaborative Profiling vs. Consensus  
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6.  U.S. Pharmaceutical Market Analysis 
In this chapter, we will discuss the analysis of the U.S. Healthcare market. We will utilize what 
we have learnt so far from the analysis of the supply chain described in Chapter 5.  But given the 
high level of uncertainties and complexity that characterize this system, we propose a new 
scenario development approach to deal with the market shaping forces. 
6.1 A Systems Perspective 
To be sure, thinking about the future of a complex system requires us to first understand its past. 
Hence, we undertook a brief historical overview to grasp the forces that led us to the current 
situation and then envision the forces that may reshape the whole industry in the future. 
6.1.1 The Cure of Disease: a Historical Perspective. 
As mentioned in the introduction, this thesis will focus essentially on the cure of disease and not 
the care of health (Glouberman and Mintzberg, 2001a). Curing diseases is result of an intangible 
service and tangible products. The real value is not only in the product or the process that cure us 
but also in the knowledge that leads to pinpointing product or process as a potential solution.  
 
In early ages, human beings used natural products to cure symptoms without even knowing the 
effects of such products on their metabolism. From Ancient Greek to current times, this 
knowledge of potential cures has been codified and transferred from one generation to the other. 
Overtime, the amount of knowledge became so important and complex that it required 
specialized training to master it. To put this in pure economic terms, the information cost became 
too high for an individual that efficiency and equity rationales prompted the need for a dedicated 
“knowledge keeper” namely the doctor.  
 
Even though the introduction of knowledge specialists appeared logical, necessary and benign, it 
created confusion on who is really making the decisions. Is it the patient or the doctor? Instead of 
eliminating asymmetries of information, the foundation of the modern medicine generated 
concerns about imperfect consent. Do you, as a patient, have all the information in hand to make 
an educated choice? 
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The situation became even more complex with the development of competitive markets. 
Pharmaceutical companies and other insurers understood the power of doctors in the patient’s 
decision making process and immediately saw the benefits of influencing doctors and surgeons 
through direct marketing (e.g. sales representatives), conferences and other means. 
 
From a historical perspective, Healthcare is all about information and knowledge. The evolution 
that the U.S. system followed led to a more complex management of a simple information flow: 
which product or procedure for which symptoms or disease. Furthermore, complexity in an 
information market usually results in the triumph of middlemen. Middlemen identify 
asymmetries of information as business opportunities and if they are the only ones to understand 
this complex system and/or if they are the ones creating the complexity, they tend to gain a great 
deal of control (WSJ, 2006a,b,c,d,e). In such circumstances, seemingly rational behaviors of 
agents at the local level lead to a suboptimal outcome for society as a whole. 
 
Needless to say, all this complexity creates an unduly convoluted health system. An interesting 
analogy could be drawn as follows.  Person “A” goes to a local franchise restaurant and sits 
down at a table to eat. Person “B” arrives, looks at the menu, and places an order for “A”. “B” 
orders a Diet Coke for “A”, but it is told the restaurant only offers Diet Pepsi, not Diet Coke. “B” 
leaves, and “A” consumes his/her meal. “A” pays only 15% of the restaurant bill, then leaves. 
“C”, from Aggregated Eaters, Inc. arrives, picks up the restaurant bill, demands a volume 
discount, and then pays the restaurant the discounted amount. This is the U.S. health care! 
(Source: Berndt, Ernst “What Differentiates Health Care from Other Industries? An Anatomical 
Overview”) 
 
Few people are capable of tracing the exact flow of goods and money in the Healthcare supply 
chain. Therefore, analyzing this market can be a challenging experience without a clear and 
simple framework. The cure of disease has always been about making an educated choice based 
on the best information available. Hence, we will first focus on market forces that prevent us 
form clearly identifying the decision maker. Indeed, the current decision-making process results 
from the trade-offs between three main players: 
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 The patient: he/she is supposed to make the final decision but asymmetries of 
information results in imperfect consent and incentives for adverse selection. It is 
worth noticing that patients are egoist since they are focused on their survival. 
 
 The practitioners (e.g. doctors, pharmacists, surgeons, etc.) are the historical heirs 
of the medical knowledge. The Sermon of Hippocrates invites them to act in the 
best interests of the patients; they should be drivers of equity. Yet, patients and 
market lobbying sometimes blurs their judgment. 
 
 The payer (e.g. insurers) funds the requested interventions and drugs.  Their 
agenda varies but is often unclear as they have a hard time figuring who is their 
customer and what are their best interests (curing once and for all with an 
expensive treatment that may not work or alleviate pain using a long but low cost 
solution). 
 
Figure 18 Healthcare Decision Triangle 
 
6.1.2 Three Flows – A Supply Chain View 
Interestingly, the triangle shown in Figure 18 also reminds us of the three flows that characterize 
a supply chain: money, information and physical goods (Chopra and Meindl, 2006). Each corner 
of the triangle represents a specific flow. Practitioners manage the information, the patients 
receive the physical product (i.e. the drug) and finally, the payer funds the transaction of 
information and physical goods. The U.S. Healthcare system, and specifically the pharmaceutical 
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business, present a peculiar situation wherein the three flows that define a supply chain are not 
intertwined as previously illustrated in our short story about U.S. Healthcare (see Section 6.1.1). 
This situation is unlike most other industries where the same players manage these three flows.  
As a result, a supply chain perspective is all the more valuable to our objective of analyzing this 
system.  
 
Our historical overview revealed the crucial importance of information in the system. Therefore, 
we focused on the information flows between the key players to initiate the analysis. We will 
particularly highlight the importance of asymmetries of information, as we believe that Market 
failures are the main source of inefficiencies in the U.S. pharmaceutical market. Indeed, the U.S. 
government intervenes more as a market player (e.g. Tricare) than a market rule maker. It 
deliberately decides not to exercise the full extent of its bargaining power (NYT, 2007). 
Therefore, government failures are a weaker driver of inefficiencies as mentioned before. 
Furthermore, the Market failures are potential challenges to this system in the future so we will 
translate them into future uncertainties in the Section 6.4. 
6.1.3 Market Failures Analysis 
In reality, any relationship in this triangle is not efficient because of information asymmetry. We 
will identify and characterize information asymmetries that have the potential to undermine the 
efficient flow of information and knowledge. 
 
Figure 19 Healthcare Decision Triangle Crippled by Information Asymmetries 
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Information Asymmetry between Practitioners and Patients 
This information asymmetry is driven by the fact that consumers know little about the 
practitioners’ record (Porter and Teisberg, 2004). Except word of mouth, no information is 
publicly available to assess the quality of a particular doctor or surgeon. How many similar 
surgeries did he/she successfully perform? How knowledgeable is he/she on diabetes? The lack 
of public record prevents patient from making an informed decision; there is imperfect consent. 
 
However, the progress in technology and access to information (e.g. the Internet) is inverting the 
asymmetry of information. For instance, patients have free access to HIV testing and are not 
obliged to share the results with his/her physician. In the past, some of the patients took 
advantage of this asymmetry of information to get their doctor’s referral for life insurance 
without mentioning their HIV positive status (Dixon, 2007). The growing connivance between 
practitioners and employers or insurers give people’s the incentive to hide critical information 
from their doctors. Why would you release information that will be detrimental to your insurance 
coverage or job? 
 
Information Asymmetry between Payers and Patients 
The payer / patient relationship is threatened by the risk of adverse selection and moral hazard. 
This issue is particularly significant in the insurance and health benefits market. To reduce the 
negative effect of adverse selection, insurance companies choose to shape their risk pool. They 
raise the rates of unhealthy patients and target low risk situations that only large payers and 
employers can propose. The threat of adverse selection has driven the disease cure system 
towards less equity and more ineffective incentives.  
 
Providing discounts for big accounts does not make medical sense as well as reimbursement 
practices that encourage physician to quickly discharge patient and readmit them if needed 
(Porter and Teisberg, 2004). The compartmentalization in preferred network to control 
information and diminish risks raises serious issues of discrepancies in coverage and 
accessibility. This type of behavior drives health costs up and nurtures moral hazard: high 
insurance costs will invite people to adopt costly behaviors to justify the premium they pay e.g. 
going to the ER for a cold! 
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Information Asymmetry between Payers and Practitioners 
The current incentives in the U.S. Healthcare system place payers and practitioners right in the 
middle of liar’s poker game. Physicians have no incentive to spend extended time with a patient 
and truly cure their disease. On the contrary, they would be better off if the patient is readmitted 
to deal with the same problem! HMO and insurers have interest in assessing the quality of 
doctors, which further increases the health bill. This is a classic Principal/Agent problem. Hence, 
in the end, it results in a suboptimal outcome despite the rational behavior of all the agents. 
  
All these asymmetries result in more complexity and golden business opportunities for third 
parties intermediaries. The complexity creates incentive to shift costs across the system so that 
nobody really knows who is paying what. Middlemen will propose to shield players form risks 
arguing that it is more efficient for one player to gather all the information given the high 
information costs. Pharmacy Benefit Management (PBM) companies offer their services to 
employers and HMOs to find the best price for a given drug. Last year, the big three PBM 
recorded a net income of nearly $2 billion (WSJ, 2006c). Middlemen are taking advantage of 
information asymmetry to build their business model. 
 
Clearly, the current situation is very unstable. Demographics signals as well as technology 
breakthroughs (e.g. gene screening) threaten the continuation of status quo represented by the 
current “competitive” system. Governments have always strived to control abuses but the current 
policies: labeling, judicial protection through tort and pure command and control regulations 
(e.g. FDA drug approval) will not compensate for the extra pressure created by the 
aforementioned factors. Indeed, as recent legal cases proved, pharmaceutical companies tend to 
hide valuable information from patients to protect their investments. For example, the side 
effects cited in a TV commercial are only the truncated list of symptoms people should monitor 
after taking the drug. Governments tried to minimize those effects through labeling and strict tort 
law. Nevertheless, this shielding is not enough considering U.S. legal history; even the high 
penalties are not significant enough to force pharmaceutical companies to publish early warning 
signs on a blockbuster.  
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In short, a total rethinking of the system is necessary to make the system more efficient. But, 
how can we prepare organizations to change in the midst of such complexity and uncertainty? 
How can we go beyond the challenges of today to understand the true driving uncertainties and 
trends? How can we leverage the uncertainties and trends to develop effective future scenarios? 
6.2 SC2020 Framework to Market Analysis 
Given the specificity and the complexity inherent to the U.S. pharmaceutical industry, our 
previous approach to scenario planning, as described in Chapter 5 may not be effective although 
our objective still remains to challenge mental models. This will in turn requires us to obtain a 
deeper understanding of key uncertainties and trends that may re-shape the industry as we know 
it today. Hence our approach needs to be more inductive and driven by industry nuances.  
 
To this end, we propose a new methodology based on the analysis of pharmaceutical industry 
trends and uncertainties. The following sections (6.2.1 and 6.2.2) describe the core beliefs that 
motivated this new framework. The key steps of this methodology are presented in Section 6.2.3.  
For a more a detailed treatment of this framework and related core beliefs we refer the reader to 
our working paper “A Framework to Plan for the Future” (Singh and Lagarde, 2007).  
6.2.1 Leverage Not Control 
From the Sun Tzu’s “Art of War” to the invention of game theory, military strategists have 
heavily influenced the Western style of business management techniques. The word that comes 
to mind when thinking about military strategy is control - whether it is the control of your 
soldiers or your environment. This thirst for control is behind the fatal attraction to predict the 
future. Predictability is in effect achievable if one succeeds in controlling the causal decision 
making in his/her organizations e.g. if X happens, my units will do Y. Military organizations 
usually rely on heavy training to ensure high degree of control. 
 
It is clear that this desire for control is predominant in the Western style of management as well. 
The industrial revolution combined with the emergence of management as a science provides 
several reasons fueling this desire for more control. In simple terms, the human factor has been 
slowly reduced to numbers; numbers have been factored into forecasts and systems reactions 
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have been cautiously converted into standards procedures e.g. an increase by 0.4 man-hour will 
lead to a 2% increase of productivity. 
 
Although a control laden approach works well in a deterministic environment, it is counter 
productive in highly uncertain times.  This desire for control has led many organizations to 
overlook potential new opportunities or act ineffectively in recent times. Control requires 
standards and replicable outcomes. Indeed, as the Indian saying asserts: “when you are a 
hammer, everything looks like a nail”. That is why we advocate leveraging instead of 
controlling. In our opinion, going forward, leverage will be the key operative management 
phrase and not control. 
 
To draw a simple analogy, leveraging is what distinguished great sailors from good ones. 
Leveraging our environment requires us to get “detached” from the past to reach the goal. One 
rarely wins a regatta by taking the shortest path or the same ones we usually take to win. 
 
Furthermore, the desire to control is ingrained in the human nature. The need to control the 
environment makes uncertainties disappear behind a wall of assumptions. While this may be 
acceptable in the short to medium term, the high uncertainties inherent in long-term planning 
make this type of behavior particularly dicey. To overcome these shortcomings, we propose a 
framework around the understanding and leveraging of uncertainties.  
6.2.2 Uncertainties Not Trends 
When it comes to thinking about the future of an organization, most people rely on trends to 
provide them with the necessary insights. It is common to find many seminars where futurists 
come and present the trends that will shape the future of the company or the industry. Even 
before questioning the accuracy problems associated with trend predictions, we wonder if trends 
can be a source of sustainable competitive advantage. 
 
Note that at the most, a trend will give you the direction of future state but not the actual path. 
Examples abound to prove that knowing a trend is important but of no value if you do not follow 
the right path. As an example, Apple was certainly one of the first companies to pick up the trend 
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of high portability: with the advances in computer miniaturization, people would soon be able to 
manage their business life with one palm-size tool. Apple launched Newton in 1994 (Figure 20) 
long before anyone else. This hand-held device featured hand writing recognition as well 
optional wireless capabilities. In 2006, CNET compared the Newton and the latest Samsung Q1 
and the Newton was found better (CNET, 2006). Why is it then that Newton is not a player in 
this fast growing segment?  
 
 
 
 
 
 
 
 
Source: Wikipedia, http://en.wikipedia.org/wiki/Apple_Newton, accessed 04/05/07 
Figure 20 Apple Newton & Samsung Q1 
 
 
Apple certainly picked-up the high portability trend before anyone. The direction was the right 
one and the final vision correct i.e. people will use hand-held devices to manage their business 
life. Yet, the high prices and poor preliminary quality of the handwriting recognition software 
failed to place them on the right path. Additionally, people were also not yet ready for such a 
device and education was first necessary to make them see its value. Later, Palm products 
succeeded by correcting the path that Apple took. 
 
In other words, the value resides not only in knowing the trend but also in the understanding of 
the uncertainties attached to it e.g. are people ready to change the way they write?  The analysis 
of the uncertainties that will shape the industry is thus of paramount importance for long-term 
planning as these uncertainties will act as constraints as well as opportunities. 
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6.2.3 Key Steps 
Our methodology relies on two important inputs: the analysis of trends and uncertainties as well 
as the understanding of the trade-offs between the key decision players that will impact the 
future of the industry. 
 
Step 1: Exploring the Macro Factor Environment  
In Section 4.2.1, we showed that a characterization of the driving forces in an inductive approach 
was of paramount importance (Figure 6). In this case, the key driving forces are presented in the 
form of uncertainties and trends. A closer look revealed that these trends and uncertainties can be 
segmented into three categories namely, Short-Term Uncertainties (trends that we know will 
happen in the long-term but very uncertain in the short-term e.g. the “green revolution”), Long-
Term Uncertainties (trends for which the short-term unraveling is fairly well known but the long-
term end state is fairly uncertain e.g. price of oil) and True Uncertainties.  
 
To implement this idea, we developed a three-step assessment tool as described in Table 6. This 
taxonomy forces organizations to explore the potential impact of each trend and uncertainty on 
their organization in significant detail. Incidentally, this is also the first step towards the 
identification of the “sensors in the ground” that a company should monitor as the future unfolds. 
 
 
Source: Scenario Planning Workshop, Cambridge, MA, March 27-28, 2007 
Table 6 Three-Step Trends and Uncertainties Assessment 
 
 First steps towards 
“what if?” thinking 
 “Flip” the current beliefs - 
“Why Not?” 
(Ayres & Nalebuff, 2003) 
 Understand the Driving 
Forces 
 Assess the range of 
potential outcomes 
Step 2: 
Explore 
 Moving towards 
“scenario thinking” 
 Spider Web Chart 
 Sensors in the ground 
 Analyze and 
Characterize what it 
means to your 
organization 
Step 3: 
Reflect 
 Best remedy against 
blind spots 
 Literature review, 
interviews etc.  
 Be curious! 
 Acknowledge the 
presence of 
uncertainties 
Step 1: 
Identify  
Result Methodology Objective  
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Identify: The scenario development team is responsible for identifying future trends and 
uncertainties. Both primary (e.g. interviews) and secondary research (e.g. external reports) 
constitutes key sources of uncertainties and trends. The team will write small paragraph 
explaining why this trend or uncertainty is worth considering. This it the identification step 
(Figure 21). 
 
 
Source: Scenario Planning Workshop, Cambridge, MA, March 27-28, 2007 
Figure 21 Trend Example - Identification step 
 
Explore: The scenario development team will then propose two directions that the uncertainty or 
trend can take. Conventional wisdom is always a safe choice to get the most obvious side of the 
story. However, by “flipping” it, the team will create another very challenging direction (Ayres 
and Nalebuff, 2003). Then, the scenario development team can either explore these two 
directions on its own by considering the driving forces behind the uncertainty/trend or ask other 
scenario users to do it. This is the explore step (Figure 22). 
 
 
Source: Scenario Planning Workshop, Cambridge, MA, March 27-28, 2007 
Figure 22 Trend Example - Explore step 
 
Reflect: Finally, either the scenario development team or the other scenario users will fill out a 
spider web chart. This chart invites them to rate several factors namely: speed of evolution, 
speed of impact, magnitude of impact, scope and level of uncertainty. Potential “sensors in the 
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ground” will also be singled out in this step. A short paragraph will conclude the organization or 
team’s position about this trend or uncertainty after brainstorming. This uncertainty or trend will 
fall into one of the three aforementioned categories. This is the reflect step (Figure 23). 
 
 
Source: Scenario Planning Workshop, Cambridge, MA, March 27-28, 2007 
Figure 23 Trend Example - Reflect step 
 
These three steps are collectively shown in a single card called the factor card (Appendix II). It 
allows external users to capture all the relevant details about this trend or uncertainty at one 
place. 
 
\Step 2: Market End States Generation 
Exploring a market driver provides its share of insight. Yet, true complexity arises when 
overlaying of market drivers leads to unexpected results. Nevertheless, it is very easy to structure 
the previously created uncertainties into challenging end states or small scenarios.  
 
The framework we developed for this step is inspired by the approach Shell took in its latest 
scenario development exercise (Shell, 2005). First of all, it requires the identification of key 
decision players that will shape the future of the industry. Is it the customer? the consumer? the 
manufacturer? or, the government? There is no exhaustive list of potential key decision players. 
It is the scenario team’s responsibility to identify the key players through interviews and 
workshops etc. Our experience suggests that identifying three players is usually good enough to 
form a solid foundation to develop rich scenarios (Figure 24). The internal portion of the triangle 
represents all the possible futures for the industry based on the different levels of interaction 
amongst the three players. 
- 58 - 
 
Figure 24 Triangle of Decision 
 
 
It should be noted that this framework is merely a tool to channel and structure people’s 
imagination. It will never ensure complete exhaustiveness but it will lead to the creation of rich 
and challenging situations, which is the first objective of Market analysis.  After the construction 
of the triangle and selection of “two wins, one loss” trade-offs, we will overlay them with some 
of the previously analyzed uncertainties. Specifically, one side of the uncertainty will be picked 
and a story will be built based on those “what if?” situations (Figure 25).  
 
Figure 25 Trade-Off Analyses of Uncertainties 
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Step 3: Market Final Scenarios Generation 
The scenario development team will then provide a list of questions to move towards strategizing 
and to identify the sensors in the ground that the scenario users will have to track. There is no 
pre-set list of question although some of them will be recurrent e.g. who is your consumer? What 
should be on your agenda? etc.  These small scenarios can either be considered as segments of 
the market in themselves or combined to form a broader picture of the future market. 
6.3 Results 
The following sections describe how we used the proposed methodology to create different 
snapshots of the U.S. pharmaceutical industry in 2020. 
6.3.1 Uncertainties and Trends 
Our literature review and interactions with “Big Pharma” executives provided us with a few 
trends and uncertainties that we tested in two different workshops – with our pharmaceutical 
partner (Cambridge, MA, 01/23/07-01/24/07) and supply chain executives from various 
industries (Scenario Planning Workshop, Cambridge, MA, 01/27/07-01/28/07). We discussed 
these trends and uncertainties in the breakout sessions using the aforementioned factor cards 
(Appendix II) following our three-step framework i.e. identify, explore, and reflect.  
 
Each uncertainty and trend is presented as a two-side uncertainty (Table 7). All the following 
material is a direct output from our workshops. 
Description Side a Side b 
Government Power Rule-Taker Rule-Maker 
Emerging Markets Source of Expansion Source of Complexity 
After-Patent Life of a Drug Generic Blockbuster Opportunity for Customization 
“Big Pharma” Pricing Strategy Price-Setter Price-Taker 
Hi-Tech Screening Devices Discrimination Amplifier Prevention Facilitator 
R&D Environment “Networked Pharma” “Chinese Wall Pharma” 
Biotech Revolution Revolutionary Products Deceiving Results 
Community of Care Highly-Certified Membership “Open-Source” Community 
Table 7 Pharmaceutical Industry Uncertainties and Trends 
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As an aside, we noticed that only a very few people were able to think about their industries in 
terms of uncertainties, in most cases the discussions about the future tended to revolve around 
trends.   
6.3.2 Market Snapshots 
Who are the key decision players in the U.S. pharmaceutical Industry?  Our market failures 
analysis demonstrated the power and robustness of the triangle of decision defined by payers, 
patients and practitioners (Figure 18).  
 
Hence, we decided to use the same triangle to structure the snapshot generation sessions. In each 
workshop, we divided the audience into three groups; each of which received one particular 
trade-off “two wins, one loss” to study. Each group used the previously analyzed uncertainties to 
develop challenging future pictures of the U.S. pharmaceutical business environment. To 
promote healthy and in-depth discussion, we also provided them with nine questions that helped 
them explore the newly created worlds: 
 
 Who is your consumer? 
 Who has the most power in the value chain? 
 Who are your competitors? 
 What is the basis of your competitive advantage? 
 Where do your margins come from? 
 What skills and capabilities make you unique? 
 What are the corresponding products and services? 
 What are the top three opportunities and threats? 
 What are three key supply network characteristics in this environment? 
 
Finally, we asked each group to choose a title for their description of the world. For ease of use, 
we developed a Story Board card that allowed accessing all the necessary information at one 
place (Appendix III). The results of the breakout sessions are summarized in the following 
figure. 
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Source: Scenario Planning Workshop, Cambridge, MA, March 27-28, 2007 
Figure 26 Pharmaceutical Industry Market Snapshots 
 
6.3.3 Market Scenario 
The stories created so far can be considered as scenarios. Yet, they lack story telling component 
and connection to the present times that makes scenarios very effective.  Roberto Perez-Franco, a 
PhD student in our research group, leveraged different “bits of story” and wove them into a 
much more captivating story (Appendix IV.) 
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7.  Synthesis and Recommendations 
During the course of the research, we learnt a lot of lessons that changed the way we thought 
about the U.S. pharmaceutical industry. Each research activity led our thoughts into uncharted 
territories and helped us refine our ideas and understanding of the sector.  The workshops were 
clearly the most challenging and unusually rewarding aspect of the whole project.  In this 
chapter, we will summarize some of the key lessons we learned from different workshops and 
other research activities to carry out the investigation of the U.S. pharmaceutical industry. We 
also present the next steps and potential research directions to further this work. 
7.1 Towards Global Scenarios 
Our experience during the course of this research has convinced us that scenario thinking is a 
simple and effective tool to stimulate forward thinking. Yet, for it to be of real value to 
organizations, concrete actions must follow this endeavor? Indeed, one question that questions its 
effectiveness is: why are companies reluctant to use scenario planning if it is so powerful?  
 
In our opinion, the main reason behind the unimpressive record so far seems to be the fact that 
despite being highly qualitative in nature, scenario planning exercise requires rigorous analysis 
of huge amounts of current data to be effective. And, few companies can afford this kind of 
investment. Furthermore, organizations have to follow a highly disciplined approach to allow the 
process and terminology to become a part of the company culture.  In many ways, the key 
benefits of scenario planning accrue over time - mostly intangible and indirect.  As a result, 
absent direct and immediate results, it is quite easy for organizations to lose faith in scenario 
planning process and abandon it by declaring it ineffective rather prematurely.  Nevertheless, we 
argue that scenario planning can be successfully used without going through the typical time-
consuming process. 
 
We also believe that many scenario planning exercises failed to deliver because they were just 
regarded as a “fancy” forecast experiment. Instead of having one end state, the organization had 
three or four of them. To draw an analogy, let us do a thought experiment about the future of the 
oil price. Suppose we can go back in time and find ourselves living in November 2001 and our 
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objective is to predict the future of oil prices in the next five years. After some sophisticated 
analysis of the historical data, suppose we arrive at an accurate “point forecast” of $55 per barrel 
in five years (Figure 27). But, herein lies the problem even with the extraordinarily “lucky” 
guess of $55: is there any competitive advantage attached to this forecast? Although we know 
the final point forecast with precision but what about the price volatility during the course of the 
five years? How will such volatility impact the revenues? costs? How can we take price volatility 
into account especially during highly uncertain times? 
 
 
Figure 27 Price of Oil - Point Forecast 
 
This is where scenario thinking comes to the rescue (Figure 28). By looking at three diverse 
pictures of the future, we are more likely to be better prepared for different possible price ranges. 
However, if the outcome of the scenario exercise remains limited to those three pictures, we have 
effectively created a “fancier” tool for point forecasting. The problem of variability is still 
unaddressed. 
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Figure 28 Price of Oil - Three Scenarios 
 
The key to success is instead the use of the scenario thinking concepts to challenge underlying 
beliefs and “thinking outside the box” (Figure 29). By forcing an organization to consider a vast 
range of possibilities, we can unlock hidden mental models and emphasize the importance of the 
path leading up to the future (as discussed in Section 6.2.2)  
 
 
Figure 29 Price of Oil - Thinking Outside the Box 
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Nevertheless, “thinking outside the box” is not an entirely suitable mindset for decision-making. 
Unlimited options and possibilities often paralyze decision makers. Hence to be effective, we 
need to “think inside the box” (Ayres and Nalebuff, 2003) to narrow down the possibilities and 
paths to consider. To this end, the merged market and supply network scenarios into three or four 
comprehensive global scenarios help redefine the “box” with new boundaries to facilitate 
practical thinking (Figure 30).   
 
 
Figure 30 Price of Oil - Think Inside the Box 
 
7.2 Evaluating Scenario Planning Implications 
Each one of the global scenarios previously created is subject to a deeper analysis using a set of 
predefined questions.  This analysis helps the decision makers obtain a better sense of the impact 
of different macro factor environment on key business aspects.  Furthermore, the team is asked 
to think of response if the presented world were to come to fruition.  At the end of the whole 
process, the team has a greater appreciation for the external forces and a good sense of options 
available to the organization under different situations.  But in itself, this information is still not 
actionable.  
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To make better sense of the responses collected from the decision makers under different 
scenarios, often labeled as Scenario Implications, a simple process is deployed to analyze them 
(Figure 31). 
 
Source: Singh M., Lagarde L. (2007), “A Framework to Plan for the Future”, Working Paper, February 22, 2007 
Figure 31 Scenario Implications Analysis 
 
A simple way to categorize scenario implications is to group them into robust and contingent 
implications.  Specifically, all the response (scenario implications) that didn’t change when the 
external macro factor environment changed fell under the category of robust implications, all 
others are labeled contingent implications. Within the robust implications category, a strategic 
option that appears to be beneficial in every scenario is called a ‘no brainer’, a ‘no regret’ 
implication is a strategic option that will be beneficial in one or two scenarios but neural in the 
others. A ‘no gainer’ implication is usually a current strategy feature that will suggests that it has 
a negative impact in every scenario and thus should be abandoned immediately. 
Typically, most scenario implications fall under the heading of contingent implications and 
present opportunities and threats of high impact without common pattern across the scenarios. 
Being contingent on a particular scenario, these implications force a more detailed review and a 
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comprehensive risk management approach before implementation. Sensors in the ground form a 
key part of the solution and should be further studied to secure a timely reaction to any change.  
7.3 Healthcare Policy Recommendations 
Although work on this project is still ongoing, our research has uncovered some interesting 
insights on the U.S. Healthcare system as a whole.  We will now present some salient ideas 
based on our enhanced understanding of this sector. 
7.3.1 Designing a New Healthcare Policy: Options and Dangers 
In most cases, any attempt to correct the U.S. Healthcare system has resulted in unexpectedly 
poor outcomes. We believe that any major change should follow a holistic approach instead of 
being driven by a multitude of locally optimal solutions. As Michael Porter and Elizabeth 
Teisberg underlines in their papers, competition is the root of the problem but also the solution 
(Porter and Teisberg, 2004). Yet, given the current pressure on Healthcare spending, the 
government is bound to intervene eventually. Our current decision triangle does not directly 
cover such a case (Figure 18); yet, it can be easily tuned to analyze the first-order impact of any 
governmental action. 
 
Involvement of government as a rule-maker is bound to generate divergent scenarios.  Clearly, 
the active role of government will reshape our decision triangle through regulations or otherwise. 
Indeed, governments usually respond to information asymmetries through four different types of 
policies 
 Laissez-Faire; 
 Provide information on risks and precaution (labels); 
 Judicial protection through torts; 
 Command and control regulations. 
 
At the same time, other main decision players will strive to shape the political outcome in their 
own best interests by influencing government’s action leading to unexpected potential failures 
(Figure 32): 
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Figure 32 The Government Impact on the Healthcare Decision Triangle 
 
 Payer / Government Interaction.  
Especially in times of high uncertainty, markets and payers will pressure government to 
adopt regulations that will enhance their competitive advantage while protecting their 
current market. Lobbying and bargaining costs will also drive costs up. In political 
science literature, these cases are referred to as Stiglerian regulatory capture. 
 
 Patients / Government Interaction.  
Patients will advocate in favor of an equal access and coverage thanks to the power of 
votes. Yet, this is a classical collective action dilemma; individuals will push for equity 
but are only interested in their personal coverage. Health is a very sensitive and personal 
issue. In such a case, coordination costs are very high.  
 
 Practitioners / Government Interaction.  
Practitioners have only a limited direct influence on regulators. However, a society will 
always need doctors, surgeons, nurses and pharmacists. The attractiveness of these 
careers to young people is critical to ensure the health of the population. 
- 69 - 
Any design of public policy should keep in mind both the potential options as well as the related 
risks. The convoluted interactions between the forces and drivers at play (hidden as well as 
apparent) will decide the fate of any public policy. In effect, any regulation will trigger reactions 
from the market to reshape the outcome in favor of concentrated interests. It is also known in 
political science literature as a typical Olsonian case where the diffused interests of the patient 
population will struggle to overcome the over representation of the industry’s concentrated 
interests. And yet, the diffused interests have to be considered. Finally, any regulation that may 
redefine the responsibilities or rights of practitioners bear the risks of lowering the number of 
interested students in health related careers. 
7.3.2 Healthcare 2.0 – Towards a Seamless Flow of Knowledge 
The challenge facing the Healthcare sector is fairly easy to describe: Reduce the Healthcare cost 
while increasing the quality of care? But this simple challenge leads to a host of other related 
challenges and problems such as how can we align the interests of counteracting interests inside 
the Healthcare nebula to prevent suboptimal outcome?  
 
Figure 33 The Healthcare Nebula 
 
This section should not be read as a pretentious attempt to lay the basis of a new Healthcare 
system. On the contrary, it should be treated as a presentation of interesting opportunities and 
dangerous pitfalls that recent advances in technology render possible.  
 
In many ways, technology seems to offer a potent solution to most Healthcare challenges. 
Incidentally, the “Pandora Box” is already open. Advanced gene screening technologies are now 
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freely available and it is impossible to turn a blind eye to the promising advantages of such 
breakthroughs. But these technologies also bring scores of direct and indirect problems with 
them as well.  The question then becomes how to integrate these double-edged solutions. The 
challenge is certainly not as insurmountable as it seems. The current Healthcare system is 
already using advanced monitoring methodologies to manage patient care: insurance companies 
keep track of drug expenses, diseases patterns. Employers also access the same information. 
Hence, instead of fighting against an inevitable change, we should think about ways to leverage 
these new opportunities to alleviate asymmetries of information. 
 
We have repeatedly highlighted the decisive importance of information and knowledge flow in 
Healthcare systems. To this end, the recent revolution in the information technology has given us 
the capability to enable seamless and secure exchange of standard information between a number 
of stakeholders. In other words, we can now manage information directly at the patient level and 
make the Healthcare system patient centric and patient driven. The availability and transmission 
of medical knowledge in this way can open the doors to interesting opportunities such as: 
 
 The continuous monitoring of patients health could shift our attention to prevention 
instead of last minute reaction. This change in focus is bound to drive costs down. 
But we have to be careful about selecting the information that should be monitored 
and how to protect this potentially dangerous personal data?  
 
 Computerized standard operating procedures (SOP) could be available to patients. 
Following the same treatment can efficiently cure many common diseases. For 
instance, curing a cold does not always require the intervention of a doctor. Likewise, 
after a preliminary exam by a physician, treatments for chronic diseases such as 
diabetes can benefit from the existence of standard procedures. Of course, 
computerized SOP can be designed to point out any irregularity in effects that 
requires closer attention of a physician. Recently, two British doctors used Google to 
research the solution to the case diagnoses published in the New England Journal of 
Medicine. They found the right answer 58% of the time (Tang, Ng, 2006). The 
question is then: how to make this information accessible and understandable to 
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patients? Which diseases should be considered a candidate? Should the system go as 
far as proposing Over-the-Counter (OTC) drugs as potential treatments? 
 
 Most of these improvements rely on the widespread existence of standard medical 
electronic record files that will permit data pooling on specific diseases. This is the 
direction both the U.S. and Europe are heading towards. A close monitoring of these 
projects’ success will provide valuable insights about the feasibility of our 
propositions. 
 
A lot of questions are still unanswered but the possible decrease in cost is unlikely to be enough 
to ensure voluntary participation of health insurance companies. Currently, insurance companies 
only respond to additional information by raising or decreasing premiums. They, however, tend 
to underestimate the value of such information. The pooling of personal data in an anonymous 
and aggregated fashion is likely to generate a better understanding of the prevalence of certain 
genes profiles in society e.g. 7% of the diabetes possess a certain predisposition that generates 
side-effects with molecule Y. Indeed, protection of this information will be of paramount 
importance requiring patient’s consent. Yet, in an aggregated form, such a data market would be 
highly beneficial to the pharmaceutical companies as it would reduce R&D risks by giving a 
good estimate of the market size for a particular molecule.  This could be especially useful for 
orphan drugs.  
 
Moreover, the access to patients’ genetic code, with their consent, opens the door to 
personalization of drugs. This development would trigger new revenue sources for companies 
and would increase drug efficiencies while decreasing risks of side effects. Safety tests would 
also be easier since the response curve to different doses will be better known for a given patient 
based on his/her genetic code. 
 
It will be in the best interest of the insurance companies to leverage this new data by 
familiarizing people with various diseases they may encounter. Teaching what to eat to a 
potential diabetic would lower his/her risks of serious and costly complications at later stages of 
his/her life.   
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Pharmacist should also take a more active role in delivering effective Healthcare. More educated 
patient means more sophisticated conversations about the effects of some OTC drugs as well as 
generic drugs. Patients empowered by right knowledge and information can proactively take care 
of their health leaving doctors and surgeons time to focus on more complex cases. 
 
We believe that going forward the insurance companies will specialize in insuring against 
specific diseases and hence patients predisposed by their genetic makeup. The potential of 
leveraging economies of scale by specializing on a single disease will underpin the shaping of 
insurance risk pool. In such a case, the insurance companies will not select patients based on 
their general good health as they do now. Instead they would compete to create the largest pools 
of patients with similar genetic code. Only in the long term can we expect a return to the current 
type of competition i.e. some horizontal consolidation to hedge risks and leverage economies of 
scope.  
 
In such a system, the information is a key but the control of it is even more complex and 
important. What is the level of information that should be shared with the patient? How can we 
be sure that it is the “right” information? Porter and Teisberg envision a governmental agency 
that would design the format and ensure the quality of the medical information in the same vein 
as the SEC is currently doing for corporate disclosures (Porter, Teisberg, 2004). Building on the 
idea of looking for examples in industry of faster “clockspeed” (Fine, 1998), the current 
struggles around information privacy traveling across the Internet should be closely monitored to 
analyze future “dos and don'ts” in the Healthcare domain. 
7.3.3 Final Recommendations 
As mentioned earlier, the current structure of the U.S. Health system appears to be unsustainable. 
The powerful forces of information asymmetries are too strong and it is a matter of time before 
potentially harmful information such as gene screenings or other identified uncertainties start 
wreaking havoc on the fast crumbling system. We advocate in favor of more research on how to 
develop a new Healthcare system, we call ‘Healthcare 2.0,’ where information could be 
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collected, managed and tracked at the patient level. We have discussed key opportunities as well 
as potential dangers of such a system.  
 
Despite the huge uncertainties that will have to be addressed in an “open transparent system,” it 
may be our best available solution. Conscious of the significant amount of changes that such a 
system would entail, we still do not consider it as utopian. At a first glance, the proposed system 
is close to a laissez-faire mindset; nevertheless, it can only be successful if governments succeed 
in forcing everyone to play by the same rules i.e. full transparency. Command and control types 
of regulations will help the transition by creating standards and exchange protocols. The 
keyword in our approach is education. The value of educating patients can’t be overemphasized. 
The U.S. government should start a national education campaign on health and wellness. For 
instance, health & wellness classes should be integrated in the curriculum of elementary schools.  
 
A core feature of the new system will be the disintermediation of the middlemen. Although 
opening new channels of information flow points towards a direct model, it can be a breeding 
ground for middlemen unless governments steps in to push the adoption of open-source 
standards and protocols. Mintzberg argues for the creation of a connected community of care that 
would encompass both modern medicine and alternate options such as acupuncture etc. 
(Glouberman and Mintzberg, 2001b). Thus, governments should ensure that both the content and 
format of the medical information be decided inside the “community of care” as it is the case in 
the Linux or Wikipedia communities. 
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8.  Conclusions 
In this study, we investigated how the combination of a supply chain perspective and a scenario 
planning methodology could generate an insightful and challenging research agenda to explore 
the future of the U.S. Healthcare system. We voluntarily limited the scope of our research to the 
U.S. pharmaceutical industry to maximize the benefits of our partnership with a Fortune 50 
pharmaceutical company. 
 
We described the problem in detail to grasp the full extent of the issue. The U.S. Healthcare 
system is a complex system crippled by inefficiencies and the numerous uncertainties that render 
most planning attempts ineffective. We explored different conceptual approaches to think about 
the long-term future. Provided the high level of uncertainty, we chose the scenario planning 
methodology instead of the more classical forecasting techniques. 
 
We carried out a literature review to pinpoint the latest recommendations for the U.S. Healthcare 
system. We also undertook a thorough review of the scenario planning literature. Given the 
“methodological chaos” we encountered in the scenario planning literature, we developed a new 
methodology for scenario generation based on the weighing of pros and cons from different 
scenario planning schools.   
 
Leveraging our expertise in supply chain scenarios, we generated three scenarios for U.S. 
pharmaceutical companies. We completed the picture with market scenarios following a more 
uncertainty driven approach. Both sets of scenarios were tested in multiple workshops for 
effectiveness and relevance. The excitement as well as the quality of thoughts during various 
brainstorming sessions validated the power of scenario planning methodologies to think and 
prepare for an uncertain future. In the last chapter, we laid down the next steps to take the 
scenario planning experience to the next level to identify actionable items. 
 
Furthermore, the market scenario exercise justified our supply chain perspective. In effect, a 
historical analysis emphasized the importance of considering the U.S. Healthcare system as a 
supply chain of knowledge. This framework sharpened our understanding of market 
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inefficiencies due to the constant tussle between the critical players that triggered most of our 
recommendations. 
 
Currently, the U.S. government acts mostly as a market-player than a market-shaper. Yet, we 
envision the necessity and implications of potential government actions in the U.S. Healthcare 
system. Based on this new reality, we proposed a research agenda to enable a seamless flow of 
knowledge and information in the U.S. Healthcare system. We believe that stakeholders should 
leverage the inevitable increase in information availability and testing technologies to tear down 
the walls of inefficiencies. In short, we believe that the future success of the U.S. Healthcare will 
be determined by its ability to become patient centric and patient driven. 
 
Needless to say, every transformation takes time and encounters numerous unexpected pitfalls. 
To overcome the barriers, our early conclusions invite thought leaders to seek inspiration from 
information-driven industries with faster clockspeed such as the e-Business. The U.S. Healthcare 
system will not recover with local band-aids solutions but only via a major surgery. Yet, as is the 
case in all surgeries, a lot of preparation and research as well as postoperative care will be 
required to make the procedure successful. 
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Appendix I 
Supply Network End States 
Alien Nations 
 
Nationalism dominates the Alien Nations world. Economic, commercial and political self-
interest is not a sub-text but the main plot for all countries. Citizens see the world through the 
prism of their own prejudices and values, and this is reflected in respective political systems. 
Such introspection inevitably breeds fear as each nation strives to assert and promote its own 
national agenda.  International trade receives short shrift from governments and citizens alike, 
unless it confers some decisive national advantage. As a result, globalization is severely undercut 
in this divided world. It occurs haphazardly, and only when companies are able to navigate 
through the complex arrays of laws and regulations that fence off nations from each other. In 
short, trade barriers, both implicit and explicit, impede the flow of goods. 
 
In such a compartmentalized world countries compete fiercely for natural resources. Citizens 
expect their governments to secure sources of energy that are reliable and cheap, regardless of 
the global implications. Domestic energy security and employment policies always take 
precedence over global ones. The price of oil follows a “long wave” cycle alternating between 
high and low volatility phases. But at least this preoccupation over the national share of non-
renewable resources focuses attention on energy issues. Governments are actively pursuing 
policies to find alternatives to fossil fuels such as hydrogen. Energy efficiency has moved 
beyond political rhetoric and is now a real goal that commands serious attention. Recycling, 
remanufacturing and waste management are regulated rigorously. 
 
The retreat into nationalism poses some unique challenges for companies. As countries have 
come to view their neighbors with growing suspicion, they have become fixated on the threat of 
terrorism and war. These fears are stoked by lurid stories of plots and counter-plots in the media. 
Governments have reacted by introducing more stringent regulations to protect citizens and the 
national interest, particularly in the safety area. This has made it almost impossible to develop 
international safety standards for products. Indeed, safety/security regulation is often used as a 
convenient guise for protectionism. Environmental standards are frequently deployed in a similar 
fashion. Consequently, efforts to address global problems such as climate change have collapsed 
as an increasing number of countries have chosen to adopt the “free-riding” stance of the United 
States, and pulled back their commitments from the collective international stage. Policy debates 
are centered on local air and water pollution issues, in much the same way as in the U.S. today.  
 
Companies have no option but to shoulder high compliance costs and non-tariff trade barriers. 
The lack of standardization frustrates globalization. Foreign companies have to work harder to 
compete, and may be pitted against national champions. It is difficult to leverage synergies 
across international operations or take advantage of economies of scale since companies must 
juggle competing sets of risks and opportunities in different countries. Given these obstacles, 
enterprises have shifted their sights to domestic customers, leading to a geographic concentration 
of markets. There is much emphasis on customization, as graying consumers demand 
personalized products (see demographic trends below). However, competition is fierce even in 
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this myopic world, and controlling supply chain costs is a high priority for companies large and 
small. To this end, new technology is being used to achieve substantial operational savings. 
 
Perhaps the biggest economic threat is the lack of synchronization between business cycles, as 
the world’s economic powers pursue individualistic growth strategies. An ill-defined and 
inefficient architecture for international finance is not conducive to effective coordination 
between national authorities or markets. Investors are naturally skeptical about global markets – 
they need to be enticed by high premiums to overcome their bias towards domestic investments. 
This amorphous trading system opens up opportunities for global arbitrage, not just in the 
financial community, but also through the operations of multinational corporations, as risk 
profiles vary widely across countries and institutions.  
 
Furthermore, disparate national rules and standards, protectionist measures, and security 
concerns, restrict the global mobility of migrants. Governments ensure that foreign workers 
return to their homelands when their allotted time in the country comes to an end. These 
restrictions make it difficult for countries to replace aging indigenous employees with younger, 
migrant workers, widening the demographic gaps between countries. So-called ‘knowledge’ 
workers are highly prized but foreign workers are viewed with deep suspicion, and immigration 
is an extremely emotive issue that frequently boils over into violent conflict. Countries that are 
the main sources of migrant workers resent these attitudes, further deepening the ideological 
divides that separate countries.   
 
 
Synchronicity 
 
Globalization, underpinned by the growth in democracy, has redefined the world map. 
Democratic governments have taken root in most countries, although they are still in their 
infancy in Latin America and Russia. The Middle East remains an area of uncertainty, but even 
here the notion of spreading democracy is no longer summarily dismissed as a Western plot to 
wrest power from Arab nations. All countries are prepared to enter into meaningful debate to 
reach a consensus on important issues.  
 
With this strong culture of democracy as a foundation, the advance of market globalization has 
been swift, and trade barriers between companies and countries have crumbled.  The concept of 
free trade permeates regulatory codes, regional development policies and aid programs. Trust is 
not simply a desirable asset, but a pre-requisite for doing business between companies and 
governments, and with consumers. 
 
But this is by no means a laissez-faire world devoid of conflict or stress. Companies must have a 
reputation for being trustworthy to remain viable. Integrity is a business imperative. In addition 
to offering products and services that fulfill the promise of high quality and reliability, 
companies are expected to empower shareholders to take an active role in businesses. Enterprises 
must have a clear corporate mission and firm values to retain employees and maintain a 
favorable market identity. Citizens actively campaign for a better quality of life, forcing 
governments and enterprises to aim high when formulating standards in key areas such as the 
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environment, healthcare and safety. The media, itself under constant scrutiny from a discerning 
public, holds organizations and individuals accountable for their actions. 
 
World financial markets are almost fully integrated. Short-termism is no longer an impediment to 
business planning. Investors seek to maximize value over the long term, and are prepared to give 
companies adequate time to re-structure and to strategize. Again, however, there is no room for 
complacency. Investors still demand increased profitability and improved capital productivity, 
and attach great importance to high ethical standards and social responsibility in the corporate 
world.  
 
Given these imperatives and the prevailing culture of trust, companies are far more likely to enter 
into joint ventures and consortia in the Synchronicity world. Partnering and virtual teams are 
common. In this open environment the “value web”, where entities work together to achieve 
commercial success, can reach its full potential. Co-production is a popular strategy for 
maximizing value. As a result, there are more opportunities for new entrants – including small- 
and medium-sized enterprises – providing they can establish the right connections. 
 
Information and knowledge move quickly around the globe in standardized formats, giving 
markets more uniformity. This intensifies competition since consumers demand new products 
and services to be available almost as fast as they are communicated. Running a company is a 
perpetual race to keep up with the latest fashions and technological advances. Products become 
obsolete very quickly, putting market leadership positions under constant threat. Customization 
has almost become the price of entry into markets. Companies have to be resourceful to remain 
competitive in important areas such as choosing which raw materials to use.  And they have to be 
extremely innovative and creative, particularly when integrating technology into their businesses 
to drive down supply chain costs while maintaining the quality of customer service. This is a 
never-ending process since technologies are constantly being refined and replaced by “new, 
improved” versions. 
 
People in this world are remarkably mobile as a result of relaxed regulations on cross border 
movements of products, information, and people.  The free flow of migrants has balanced the 
effects of unequal population ageing but it has increased the diversity in the population mix as 
well. The global distribution and diversity of highly competitive production resources, including 
skilled workforce, are influencing supply chain design decisions.  Furthermore, companies have 
reconciled to the fact that they will receive only partial loyalty from employees. 
 
The idea that a company’s most precious resource is its workforce has been given new currency 
in the Synchronicity world. The services associated with a product are as important as the 
product itself. Most leading companies consider software element of the products to be its main 
competitive advantage, and the only way to retain that edge is to retain the employees who 
created it.  At the same time workforces and companies have become more distributed, because 
frameworks exist that make operating across multiple jurisdictions just as cost-effective as 
operating across a single jurisdiction.  
 
There is a global consensus on environmental stewardship. A Global Environmental Mechanism 
has been created that serves as a clearing house for data, technologies and policies pertaining to 
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the replenishment and conservation of scarce natural resources. The Mechanism is a ready source 
of effective practices in areas such as pollution control and the management of natural resources. 
As a result, embedding environmental factors into pricing strategies becomes a norm. However, 
since open markets and free trade are seen as essential to achieving security of supply, the 
allocation of resources is invariably left to market forces, and weighty energy decisions tend not 
to address long-term issues. The price of oil is volatile and relatively high; although in overall 
terms fuel is more affordable since citizens of the Synchronicity world are prosperous.  
 
 
Spin City 
 
In the Spin City world globalization is driving economic growth but at a slow and uneven pace. 
Government regulation reins in the global expansion of business. A lack of trust discourages the 
kind of openness that is essential for unfettered international trade to flourish. And although the 
merits of globalization are recognized and even lauded, in this climate of suspicion a hybrid form 
of world commerce has emerged that combines respect for market forces with a high level of 
state intervention. For example, the Internet functions much like international airspace. It is a 
universal communications medium but divided into a patchwork of jurisdictions as each country 
controls the traffic that flows within its sovereign space (think of the influence that China exerts 
over Internet traffic within its borders today, and imagine that system extended across the globe).  
 
At a government level national security is a top priority. It could be argued that this is the case 
today, particularly in the United States, but in the Spin City world governments have become 
obsessive to the point where securing business transactions through regulation colors every 
decision and policy. Security issues and mistrust frame all geopolitical discussions. Governments 
have decided that markets are incapable of maintaining an adequate level of security and 
financial trust, and therefore must be scrutinized and regulated by state agencies.  
 
However, not every nation is governed by the same iron hand. Managing the issue of trust differs 
from country to country. For example, countries that have a long tradition of state intervention 
such as Russia, China and Venezuela, reinforce the regulatory systems that were already in place 
without appearing anachronistic. In countries where state agencies have been less interventionist, 
Australia and the United States for instance, there is more emphasis on using private sector 
organizations such as accountants and audit firms to enforce regulation.  
 
Despite these differences world issues are internationally addressed; supranational organizations 
and treaties such as the European Union, NAFTA and the United Nations remain important. Still, 
the fundamental lack of trust almost always frustrates consensus on a global level. 
 
The lack of consensus extends to environmental regulation as well. The state of the environment 
and the non-stop depletion of natural resources, are major concerns. Various campaign groups 
including NGOs pressure governments and companies to promote sustainable development and 
more transparency in the use of natural resources. The Kyoto Protocol is still in force albeit in a 
stagnant form. But governments’ natural response is to impose mandatory controls to protect the 
environment, mainly in the form of taxation. Recycling, remanufacturing and waste management 
activities are heavily regulated. Energy markets are governed by complex rules and regulations 
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that aim to foster competition, secure energy supplies and protect end-customers. Oil is more 
expensive in real terms than in any other world scenario, and although alternatives fuels have 
been developed, the inefficiencies created by government intervention tend to inflate the cost of 
energy.  
 
Companies have adapted to this uncertain and complex environment. In fact, on a macro level, 
there is competition between governments to develop regulatory systems that fulfill national 
security objectives while attracting private sector organizations. As a result, these systems are 
constantly changing, and companies devote a great deal of time and effort to monitoring the 
changes and re-assessing the competitive landscape.  On a micro level, the lack of trust in this 
world shapes the way enterprises do business. Profitability and capital productivity are still 
fundamental metrics. The media still thrives on stories about corporate profits and scandal, and 
publishes rankings that keep companies under pressure to perform. But investments are also 
driven by companies’ ability to inspire trust. In a world where trust is at a premium, those 
enterprises that establish a reputation for being trustworthy have a distinct competitive 
advantage. Enterprises that show a willingness to comply with regulations or even go beyond the 
call of duty also have an edge over less savvy competitors.  
 
Research and development is crucially important. The tangle of regulation that ensnares the 
commercial sector makes supply chains less efficient and introduces more cost. A way to counter 
this is to use superior technology to increase productivity and speed up information flows. There 
is more collaboration between governments, research establishments and companies, and R&D 
budgets are less prone to cuts. Even so, technical excellence is not an easy target to hit. In the 
prevailing climate of suspicion the diffusion of ideas is slow, particularly when it comes to the 
transference of ideas and technology across borders. There are legal tools available to protect 
intellectual property, but these seldom afford full protection from unscrupulous government 
agencies and competitors. As a result, the sharing of intellectual property with companies across 
borders is frowned upon. In short, creativity and innovation are curtailed.  
 
Mistrust also stymies the movement of people. Migration is restricted - ostensibly for national 
security reasons. As the flow of migrants is discouraged, it is difficult for countries to replenish 
their aging work forces with these workers. This has created demographic imbalances. In 
countries such as Germany, Italy and Japan, where the average age of the citizenry is relatively 
high, the easy availability of younger migrants is particularly troublesome. But even in 
comparatively young countries such as the United States, the limited number of immigrants is 
causing serious problems. Populations are graying, and a major issue is how to retain the 
knowledge base as older, experienced workers leave the workplace. These imbalances cause 
tensions between countries, feeding the mistrust that already exists. Ironically, restricting 
migration in the interests of national security has led to even more regulation. In an effort to 
address the imbalances described above, governments have introduced convoluted regulations 
designed to admit migrant workers in specific circumstances. 
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Appendix IV 
Market Scenario 
 
Members Only 
 
A Healthcare Market Scenario created based on the brainstorming sessions held 
during the ‘Strategy Development Using Scenario Planning’ workshop offered by 
the MIT Center for Transportation and Logistics. 
 
Faculty Club, MIT 
27th-28th March 
 
 
 
«We're almost done here. Two more minutes until the FBS is completed.»  
 
Steven walked to the room next door, while Mark remained in front of the transparent screen of 
the supercomputer, which displayed real-time 3-D projections of a patient's body. Inside the 
room next door there was a large cubicle, with a rounded, porcelain exterior. A tiny light on the 
roof turned from red to green, and the top of the cubicle opened, like a sarcophagus. There was a 
woman inside, maybe around fifty years old. A nurse offered her a white robe, and helped her get 
out of the device.  
 
«What exactly is this thing you just did to me, Dr. O'Laughin?,» asked the woman, with a sleepy 
voice.  
 
«It's called an FBS, or full body scan, Ms. Orwell. I know it's been a long afternoon for you, but 
this was the last test we had to run. You can get dressed now and go back home. Nancy, make 
sure to send Ms. Orwell's samples to the labs right away.»  
 
«What's next?,» asked Ms. Orwell.  
 
«Well, the analysis of your DNA sample should be complete before Friday. The results of all the 
other exams, including the FBS, will be in my desk tomorrow afternoon. I will have the whole 
therapy package designed by next Monday. The good news is that my colleague and I were 
looking at some preliminary images from your scan and it seems that the cancer has not spread 
to the lungs yet.»  
 
«So this means that...»  
 
«Yes, success is almost guaranteed, with the therapy we'll prepare for you.»  
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«Is it true that there are no side effects?» asked the woman.  
 
«Well - said Mark, who had just entered the room - nothing is free of side effects. But this 
therapy will be designed just for you, using the latest methods. It combines nanomedicine, which 
are like tiny machines that will destroy the malignant cells of the cancer, designed to match your 
genetic makeup, with special drugs tailored just for you, in order to minimize the discomfort 
during the healing period.» 
  
«My mother, you know... - said the woman - she died of a similar cancer thirty years ago. I 
remember that back then, the therapy was almost as bad as the disease... if she had had the 
chance I have today...»  
 
Ms. Orwell thanked them both profusely once more, and left the room. She was one of the few 
lucky ones. Most people of her class usually don't get access to such advanced health care. It is 
year 2025, in Boston, and yes, I have just used the word 'class'. Here's what happened, in a 
nutshell: the challenges of a mature information society caught many Americans unprepared. 
Millions lost their jobs to automation and outsourcing. As those without specialized skills or 
higher education had to settle for lesser jobs, the middle class was squeezed towards the poor end 
of the spectrum, while the few rich became richer.  
 
By mid 2020's, few aspects of life showed this divide more eloquently than health care. Amazing 
changes took place, sure, but very few had access to them. There was the 'biotech revolution' in 
the mid 2010's, triggered by the success of early tailored drugs for Alzheimer and diabetes. 
Encouraged by this, a myriad different efforts to develop genetically engineered drugs, both in 
universities and small private research firms, received funding from the government and large 
pharmaceutical companies. Albeit still not a totally fulfilled promised, genetic medicine and 
biotechnology scored some big-profile victories against certain types of cancer and infectious 
diseases in the early 2020's.  
 
As a sponsor of the early research, the government held a good share of the patents for this 
technology. However, the prohibitive cost of producing tailored prescriptions for the public was 
beyond what the taxpayers could afford. Thus recently, many of the governmental patents had 
been licensed to private firms, who also owned another part of the patents. Thus, customized 
medicine became a reality, but only for those who could afford it. Top-class health care, like 
diamonds, was the privilege of a few.  
 
For the rest, generic drugs and a do-it-yourself approach to health care were the best option 
available. They got their medical advice from the less sophisticated machines in smaller clinics, 
barely staffed with medical personnel that was, well, not in touch with the latest advances. The 
role of this staff, mainly nurses, was to give the patients general advice and show them how to 
use these sort of websites, where expert systems presented questionnaires to visitors in order to 
help them pinpoint their illnesses, and recommend a generic drug.  
 
«Sometimes I feel like we live in a bubble, man,» said Steven.  
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Dr. Steven O'Laughin was feeling a little under the pressure today. He looked at his partner, Dr. 
Mark Thomas, who nodded sympathetically. 
  
«What do you mean a bubble, Steve?»  
 
«You know... disconnected from the real world.»  
 
Mark and Steven didn't see eye to eye in some things. Both were educated in the best medicine 
schools of the country, but their life perspectives were very different. Mark, on his part, had no 
problem being a doctor for the elites. He felt he had worked very hard to reach his current 
position, and deserved a high compensation. In fact, the training of medical students had 
significantly changed in the last decade. As the cutting edge of medicine became both sharper 
and more inaccessible, the new doctors had to start training straight from high school, and 
graduated after more than a decade of training, already in their thirties. Mark felt like the 
member of a cluster of highly specialized experts, and billed their patients accordingly.  
 
He had no problem with having the big pharmaceutical companies compete for his attention. His 
time was valuable as gold. To get his attention and endorsement for their drugs, the 
pharmaceutical companies had to 'dine and wine' him: his office was furnished with the most 
advanced diagnostic equipment, courtesy of a group of pharma companies. In exchange for this 
and for some share in the firm’s profits, Dr. Mark Thomas gave preference to their molecules for 
every case where more than one product would work (a call that was, at the end, up to him). The 
pharma researchers also got access to detailed information on the patients, stripped of all 
identifying marks, about their healing process and evolution, to measure how well the drugs were 
performing, in order to improve their processes. As new therapies were devised, success rates 
soared.  
 
«I don't get you, Steven. Medicine has never been in a better place in its whole history!,» said 
Mark, trying to cheer his colleague up.  
 
It was true. Biotechnology had revolutionized medicine in a way only comparable to the 
discovery of antibiotics and vaccines. As medicine had transformed, so also did the pharma 
companies. To compete, firms diversified their portfolios by investing in both ends of the 
spectrum: generics manufacturing for the masses, and biotechnology ventures for the few. 
 
The high speed of change of the field forced the biotechnology and genetic medicine firms to 
develop very flexible, and yet efficient, supply chains. Similar to scouts recruiting talent for a 
major league baseball team, these firms hunted for the latest technological breakthroughs among 
the thousands of new biotech firms, licensing those products or techniques that seemed more 
promising and offer marketing and distribution capabilities in exchange. More adaptive 
manufacturing methods were developed, too, in order to produce a large array or drugs, while 
retaining the ability to ramp up or down quickly, to follow the customized and unpredictable 
demand.  
 
One of the biggest challenges for the supply chain was to retain as much visibility as possible to 
prevent counterfeits, while maintaining effectiveness and innovation. The huge value to volume 
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ratio of personalized products, with clock-like delivery precision, posed another two enormous 
challenges for the supply chains of big pharma companies. They evolved to become sorts of 
clearing houses for knowledge, managing portfolios of intellectual property developed by third 
parties, and promoting these innovative products among physicians.  
 
«I see your point, Mark - replied Steven - But it is also true that the best health care has never 
been inaccessible to so many.»  
 
Steven was right, and Ms. Orwell was a good example of this. The patients of Mark and Steven's 
office were usually upscale, and very demanding of personalized therapies. Ms. Orwell, on the 
contrary, was poor.  
 
It is an awful thing to say, but actually, if she had been rich, chances are she would have not 
developed cancer in the first place. Genetic screening tests were available long ago, to those who 
could pay for them. A simple screening could have alerted Ms. Orwell about her predisposition 
to cancer. With this early warning, prophylactic therapies could have been initiated, which would 
prevent the cancer from ever developing, or in the worst case, stopped it when it was in the 
earliest stages. But all this belonged to a different world, beyond her reach.  
 
However, thanks to the advances of medicine, her prognosis was today much better than it would 
have been a decade ago. In the specific case of Ms. Orwell, her treatment was sponsored by the 
government, as part of an exchange program in which the pharmaceutical companies offered full 
treatment free of cost for a certain number of patients selected by the government. In exchange, 
the government allowed the pharmaceutical companies to continue to use some patents.  
 
The government had political reasons for implementing this program: nicknamed the 'health 
green card lottery', it was seen by lawmakers as a way to ease the increasing social tensions 
betweens the haves and the have-nots in terms of health care. Some patients were selected based 
on the recommendation of social workers, and others were just selected at random. This, they 
thought, gave hope to some patients. Time had shown, however, that it had failed to resolve the 
increasing tensions.  
 
«I don't think this system is sustainable, Mark. I really don't,» said Dr. Steven.  
 
«Well... - lamented Dr. Mark - what can I do? I'm just a simple guy trying to do my job.» 
 
Key Sensors-in-the-Ground 
 
• The ratio of approved bio-tech and traditional drugs  
• Level of investment made by venture capitalists and private equities in biotech firms  
• Level of interest in biotech on Wall Street  
• Acquisition profile of big Pharmaceutical companies  
• U.S. political shifts in Healthcare policy  
• IP trend  
• Price protection trends  
• Increase costs of R&D and time-to-market  
